{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: tabula-py in c:\\users\\cynhe\\anaconda3\\lib\\site-packages (2.6.0)\n",
      "Requirement already satisfied: distro in c:\\users\\cynhe\\anaconda3\\lib\\site-packages (from tabula-py) (1.8.0)\n",
      "Requirement already satisfied: numpy in c:\\users\\cynhe\\anaconda3\\lib\\site-packages (from tabula-py) (1.22.4)\n",
      "Requirement already satisfied: pandas>=0.25.3 in c:\\users\\cynhe\\anaconda3\\lib\\site-packages (from tabula-py) (1.4.2)\n",
      "Requirement already satisfied: python-dateutil>=2.8.1 in c:\\users\\cynhe\\anaconda3\\lib\\site-packages (from pandas>=0.25.3->tabula-py) (2.8.2)\n",
      "Requirement already satisfied: pytz>=2020.1 in c:\\users\\cynhe\\anaconda3\\lib\\site-packages (from pandas>=0.25.3->tabula-py) (2021.3)\n",
      "Requirement already satisfied: six>=1.5 in c:\\users\\cynhe\\anaconda3\\lib\\site-packages (from python-dateutil>=2.8.1->pandas>=0.25.3->tabula-py) (1.16.0)\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    }
   ],
   "source": [
    "pip install tabula-py"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "from tabula import read_pdf"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "LSD PATENT TRACKER"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "tables=read_pdf(\"./Psilocybin Patent Tracker - Psychedelic Alpha.pdf\", pages=\"all\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[   #                                              Title  \\\n",
       " 0  1  Method of treatment based on reduced monoamine...   \n",
       " 1  2           Methods of crossbreeding fungi organisms   \n",
       " 2  3  Methods and compositions comprising psychoacti...   \n",
       " \n",
       "              Owner/Assignee Patent/Pub. No. Priority Date  \\\n",
       " 0  Lennham\\rPharmaceuticals    US11,344,564     20/8/2021   \n",
       " 1             Jerred Tudela    US11,419,280     23/7/2021   \n",
       " 2          Psilo Scientific   US20220226405     14/6/2021   \n",
       " \n",
       "                                     Status  \\\n",
       " 0  Granted 2022-5-31\\r(expires 2041-12-17)   \n",
       " 1                                Published   \n",
       " 2                                Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  The method includes determining whether a subj...  \n",
       " 1  Methods of crossbreeding fungi organisms. The\\...  \n",
       " 2  This invention relates to the extraction of ps...  ,\n",
       "    #                                              Title  \\\n",
       " 0  4  Methods and compositions relating to psychedel...   \n",
       " 1  5  Transdermal system, formulation, and method fo...   \n",
       " 2  6  Artificial expression constructs for modulatin...   \n",
       " \n",
       "                  Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0            Terran Biosciences    WO2022212854      1/4/2021  Published   \n",
       " 1  Mycrodose\\rtherapeutics inc.    WO2022212789     31/3/2021  Published   \n",
       " 2               Allen institute    WO2022212585     30/3/2021  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Provided herein are compositions relating to\\r...  \n",
       " 1  A drug delivery system is provided for transde...  \n",
       " 2  Artificial expression constructs for modulatin...  ,\n",
       "     #                                              Title  \\\n",
       " 0   7  Psilocybin compositions, methods of making and...   \n",
       " 1   8              Use of psychedelics to treat dementia   \n",
       " 2   9    Treatment protocol computer systems and methods   \n",
       " 3  10  Psilocybin analogs, salts, compositions, and m...   \n",
       " \n",
       "                 Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0  Compass Pathfinder\\rLimited    WO2022207746     30/3/2021  Published   \n",
       " 1           Mynd Life Sciences    WO2022204802     30/3/2021  Published   \n",
       " 2             Mind Cure Health    WO2022204805     29/3/2021  Published   \n",
       " 3            Cybin IRL Limited    WO2022195011     18/3/2021  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  The present disclosure provides pharmaceutical...  \n",
       " 1  The present invention provides use of psychede...  \n",
       " 2  Computer-implemented methods of treating at le...  \n",
       " 3  The present disclosure relates to psilocin com...  ,\n",
       "     #                                              Title  \\\n",
       " 0  11       Improved methods for the use of psychedelics   \n",
       " 1  12  Dosing regimens of pharmaceutical and nutraceu...   \n",
       " 2  13                    5-HT receptor agonist titration   \n",
       " 3  14  Formulations of Psilocin that have enhanced st...   \n",
       " \n",
       "           Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0      Tryp Therapeutics    WO2022195489     15/3/2021  Published   \n",
       " 1           Allied Corp.    WO2022187973     12/3/2021  Published   \n",
       " 2  Diamond\\rTherapeutics    WO2022189855      8/3/2021  Published   \n",
       " 3          Mind Medicine   US20220280482      6/3/2021  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Provided are improved methods for treating a\\r...  \n",
       " 1  The present invention discloses compositions f...  \n",
       " 2  Disclosed herein are methods of treating\\rneur...  \n",
       " 3  A composition of psilocin that is stable inclu...  ,\n",
       "     #                                              Title  \\\n",
       " 0  15  Formulations of Psilocin that have enhanced st...   \n",
       " 1  16  Synergistic cannabinoid esters, their salts an...   \n",
       " \n",
       "                                       Owner/Assignee Patent/Pub. No.  \\\n",
       " 0                                      Mind Medicine    WO2022192097   \n",
       " 1  London\\rPharmaceuticals and\\rResearch\\rCorpora...    WO2022183292   \n",
       " \n",
       "   Priority Date     Status                             General Subject Matter  \n",
       " 0      6/3/2021  Published  A composition of psilocin that is stable inclu...  \n",
       " 1      3/3/2021  Published  Cannabinoid esters and their soluble salts wit...  ,\n",
       "     #                                              Title  \\\n",
       " 0  17  Effects of lysergic acid diethylamide [lsd] an...   \n",
       " 1  18  Effects of lysergic acid diethylamide (lsd) an...   \n",
       " \n",
       "               Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0  Universitatsspital\\rbasel    WO2022175821     19/2/2021  Published   \n",
       " 1  Universitatsspital\\rBasel   US20220273628     19/2/2021  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  A method of treating anxiety disorders specifi...  \n",
       " 1  A method of treating anxiety disorders specifi...  ,\n",
       "     #                                              Title  \\\n",
       " 0  19  Multi-substituent psilocybin derivatives and m...   \n",
       " 1  20  Pharmaceutically acceptable salts of psilocin ...   \n",
       " 2  21  Methods of use and formulations of allosteric\\...   \n",
       " \n",
       "               Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0        Enveric Biosciences    WO2022170438     12/2/2021  Published   \n",
       " 1       Eleusis Therapeutics    WO2022173888     10/2/2021  Published   \n",
       " 2  David Alan Heldreth,\\rJr.   US20220265601     10/2/2021  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Disclosed are novel multi-substitute psilocybi...  \n",
       " 1  The present invention features pharmaceuticall...  \n",
       " 2  The invention involves the use of formulations...  ,\n",
       "     #                                              Title       Owner/Assignee  \\\n",
       " 0  22  Rapid method of producing non-alcoholic and al...                Ceria   \n",
       " 1  23  Rapid method of producing non-alcoholic and al...                Ceria   \n",
       " 2  24  Prenylated psilocybin derivatives and methods ...  Enveric Biosciences   \n",
       " \n",
       "   Patent/Pub. No. Priority Date              Status  \\\n",
       " 0    WO2022165387     31/1/2021           Published   \n",
       " 1    US11,521,444     31/1/2021  Granted 2022-12-06   \n",
       " 2    WO2022155751     22/1/2021           Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  A rapid method of brewing malt beverages havin...  \n",
       " 1  A rapid method of brewing malt beverages havin...  \n",
       " 2  Disclosed are novel prenylated psilocybin deri...  ,\n",
       "     #                                              Title  \\\n",
       " 0  25  Activated cannabis products and methods for\\rp...   \n",
       " 1  26  Nanoparticle-mediated immune cell manufacture ...   \n",
       " \n",
       "                        Owner/Assignee Patent/Pub. No. Priority Date  \\\n",
       " 0                2655626 Ontario Inc.    WO2022155741     20/1/2021   \n",
       " 1  The George\\rWashington\\rUniversity    WO2022150763     11/1/2021   \n",
       " \n",
       "       Status                             General Subject Matter  \n",
       " 0  Published  The present disclosure describes cannabis prod...  \n",
       " 1  Published  The present disclosure generally relates targe...  ,\n",
       "     #                                              Title       Owner/Assignee  \\\n",
       " 0  27  Systems and methods for pharmaceutical product...     Miami University   \n",
       " 1  28  Treatment of suicidality with psilocin or psil...  New York University   \n",
       " \n",
       "   Patent/Pub. No. Priority Date     Status  \\\n",
       " 0    WO2022150854     11/1/2021  Published   \n",
       " 1    WO2022150563      8/1/2021  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Provided are systems and methods for the produ...  \n",
       " 1  The invention relates to a method of preventin...  ,\n",
       "     #                                              Title    Owner/Assignee  \\\n",
       " 0  29  Psilocybin and norbaeocystin compositions and\\...  Miami University   \n",
       " 1  30  Protected alkyl tryptamines and their therapeu...          CaaMTech   \n",
       " \n",
       "   Patent/Pub. No. Priority Date     Status  \\\n",
       " 0    WO2022150840      8/1/2021  Published   \n",
       " 1    WO2022150530      8/1/2021  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Provided is a pharmaceutical composition compr...  \n",
       " 1  The disclosure relates to protected alkyl tryp...  ,\n",
       "     #                                              Title Owner/Assignee  \\\n",
       " 0  31  Composition for treating opioid withdrawal and...     Mai Nguyen   \n",
       " \n",
       "   Patent/Pub. No. Priority Date     Status  \\\n",
       " 0   US20220218649      7/1/2021  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  A composition for treating opioid withdrawal a...  ,\n",
       "     #                                              Title    Owner/Assignee  \\\n",
       " 0  32  Vaporizable psychoactive alkaloid composition ...  Psilo Scientific   \n",
       " 1  33  Transmucosal psychoactive alkaloid composition...  Psilo Scientific   \n",
       " \n",
       "   Patent/Pub. No. Priority Date     Status  \\\n",
       " 0    WO2022140846    28/12/2020  Published   \n",
       " 1    WO2022140841    28/12/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  This liquid composition includes a psychoactiv...  \n",
       " 1  A transmucosal psychoactive alkaloid compositi...  ,\n",
       "     #                                              Title  \\\n",
       " 0  34  Vaporizable psychoactive alkaloid composition ...   \n",
       " 1  35  Transmucosal psychoactive alkaloid composition...   \n",
       " 2  36  Compositions and methods for anxiety disorder\\...   \n",
       " \n",
       "              Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0          Psilo Scientific   US20220313713    28/12/2020  Published   \n",
       " 1          Psilo Scientific   US20220313762    28/12/2020  Published   \n",
       " 2  Psilobrain\\rTherapeutics    WO2022137107    21/12/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  This liquid composition includes a psychoactiv...  \n",
       " 1  A transmucosal psychoactive alkaloid compositi...  \n",
       " 2  Composition consisting of psilocybin and croci...  ,\n",
       "     #                                          Title Owner/Assignee  \\\n",
       " 0  37          Use of psilocybin in cancer treatment    Silo Pharma   \n",
       " 1  38  Dialkyl trytamines and their therapeutic uses       CaaMTech   \n",
       " \n",
       "   Patent/Pub. No. Priority Date     Status  \\\n",
       " 0    WO2022125949    13/12/2020  Published   \n",
       " 1    WO2022125616     9/12/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Methods of treating and/or alleviating prolife...  \n",
       " 1  The disclosure relates to a composition compri...  ,\n",
       "     #                                              Title  \\\n",
       " 0  39  Pharmaceutical composition comprising psilocyb...   \n",
       " 1  40  Aldehyde and ketone derivatives of psilocybin ...   \n",
       " 2  41  Novel psilocin analog compositions and methods...   \n",
       " 3  42  Carboxylated psilocybin derivatives and method...   \n",
       " 4  43     Compositions and methods for treating migraine   \n",
       " \n",
       "           Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0        Beckley Psytech    WO2022123232     7/12/2020  Published   \n",
       " 1    Enveric Biosciences    WO2022115960     4/12/2020  Published   \n",
       " 2  Mydecine\\rInnovations    WO2022120181     3/12/2020  Published   \n",
       " 3    Enveric Biosciences    WO2022115944     1/12/2020  Published   \n",
       " 4          Wesana Health    WO2022115798    30/11/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  A composition for use in a method of treatment...  \n",
       " 1  A chemical compound having the psilocybin mole...  \n",
       " 2  Novel psilosin analogs exhibiting enhanced res...  \n",
       " 3  A chemical compound having the psilocybin mole...  \n",
       " 4  Disclosure features compositions containing\\rc...  ,\n",
       "     #                                              Title       Owner/Assignee  \\\n",
       " 0  44  Compositions and methods for treating neurolog...        Wesana Health   \n",
       " 1  45                Treatment of anxiety and depression  New York University   \n",
       " 2  46  Engineered microorganisms for producing substi...              Algae-C   \n",
       " 3  47  Compositions and methods for extracting, stabi...    Richard C Kaufman   \n",
       " 4  48  Thc beverage preparation apparatus and method ...  Cave; Mason; et al.   \n",
       " \n",
       "   Patent/Pub. No. Priority Date     Status  \\\n",
       " 0    WO2022115796    30/11/2020  Published   \n",
       " 1   US20220151993    16/11/2020  Published   \n",
       " 2    WO2022099424    16/11/2020  Published   \n",
       " 3   US20220054402     5/11/2020  Published   \n",
       " 4   US20220125091    24/10/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Disclosure features compositions containing a\\...  \n",
       " 1  Method of alleviating depression and/or anxiet...  \n",
       " 2  Presented herein are microorganisms for produc...  \n",
       " 3  Invention discloses nano-dimensional compositi...  \n",
       " 4  A method for preparing and packaging a THC\\rbe...  ,\n",
       "     #                                              Title  \\\n",
       " 0  49  Cannabis time release apparatus and method of\\...   \n",
       " 1  50  Food / beverage nootropic amendment apparatus ...   \n",
       " \n",
       "           Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0   Hazen; Kevin; et al.   US20220125755    24/10/2020  Published   \n",
       " 1  Roth; Michael; et al.   US20220127058    24/10/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  A method for forming a Cannabis product, compr...  \n",
       " 1  The invention comprises a method and apparatus...  ,\n",
       "     #                                              Title  \\\n",
       " 0  51  Thc food / beverage product method of manufacture   \n",
       " 1  52  Thc container apparatus and method of use thereof   \n",
       " 2  53  Method for forming a beverage with a dissolvab...   \n",
       " \n",
       "             Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0  Reich; Alton J.; et al.   US20220125088    24/10/2020  Published   \n",
       " 1      Cave; Mason; et al.   US20220125810    24/10/2020  Published   \n",
       " 2      Michael Roth et al.   US20220241238    24/10/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  A method for amending an original food product...  \n",
       " 1  method of preparing and packaging a THC infuse...  \n",
       " 2  The invention comprises a method and apparatus...  ,\n",
       "     #                                              Title  \\\n",
       " 0  54  Process for obtaining a purified psychoactive ...   \n",
       " 1  55  Use of benzodiazepines to increase sensitivity...   \n",
       " 2  56  Compositions for reducing inflammation to impr...   \n",
       " 3  57  Deuterated derivatives of psilocybin and uses ...   \n",
       " 4  58  Deuterated derivatives of psilocybin and uses ...   \n",
       " \n",
       "              Owner/Assignee Patent/Pub. No. Priority Date  \\\n",
       " 0          Psilo Scientific    WO2022082320    23/10/2020   \n",
       " 1        Compass Pathfinder    WO2022084480    21/10/2020   \n",
       " 2  Goodcap\\rPharmaceuticals    WO2022079574    12/10/2020   \n",
       " 3  Lennham\\rPharmaceuticals    US11,324.762     8/10/2020   \n",
       " 4  Lennham\\rPharmaceuticals  US11,000,534B1     8/10/2020   \n",
       " \n",
       "                                      Status  \\\n",
       " 0                                 Published   \n",
       " 1                                 Published   \n",
       " 2                                 Published   \n",
       " 3  Granted 2022-05-10\\r(expires 2040-12-10)   \n",
       " 4  Granted 2021-05-11\\r(expires 2040-12-10)   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  A psychoactive alkaloid source is used to obta...  \n",
       " 1  A method of administering psilocybin to a subj...  \n",
       " 2  A composition comprising a therapeutic combina...  \n",
       " 3  Compositions comprising deuterated derivatives...  \n",
       " 4  Pharmaceutical compositions of deuterated psil...  ,\n",
       "     #                                              Title  \\\n",
       " 0  59  Deuterated derivatives of psilocybin and uses ...   \n",
       " 1  60  Novel psychedelic compositions, delivery syste...   \n",
       " 2  61  Novel formulations of psilocybin and psilocin\\...   \n",
       " \n",
       "              Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0  Lennham\\rPharmaceuticals   US20220110955     8/10/2020  Published   \n",
       " 1     Mydecine\\rInnovations  WO2022072808A1     1/10/2020    Pending   \n",
       " 2     Mydecine\\rInnovations    WO2022061196     18/9/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Compositions comprising deuterated derivatives...  \n",
       " 1  Combinations of at least one psychedelic compo...  \n",
       " 2  Use of novel formulated psilocybin and/or psil...  ,\n",
       "     #                                              Title  \\\n",
       " 0  62  Methods of quantifying psilocybin's main metab...   \n",
       " 1  63  Psilocybin in patients with obsessive-compulsi...   \n",
       " 2  64  Nitrated psilocybin derivatives and use thereo...   \n",
       " 3  65  Cellular composition for treatment of diseases...   \n",
       " 4  66  Halogenated psilocybin derivatives and methods...   \n",
       " 5  67  Hydroxylated psilocybin derivatives and method...   \n",
       " \n",
       "                Owner/Assignee  Patent/Pub. No. Priority Date     Status  \\\n",
       " 0   Universitatsspital\\rBasel  US20220082578A1     12/9/2020  Published   \n",
       " 1             Yale University    US20220062310      3/9/2020  Published   \n",
       " 2         Enveric Biosciences     WO2022047583      2/9/2020  Published   \n",
       " 3  YZTherapeutic\\rPerformance     WO2022049574      2/9/2020  Published   \n",
       " 4         Enveric Biosciences     WO2022047579      1/9/2020  Published   \n",
       " 5         Enveric Biosciences     WO2022047580      1/9/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  A method of measuring and identifying metaboli...  \n",
       " 1                            Psilocybin to treat OCD  \n",
       " 2                      Nitrated psilocybin compounds  \n",
       " 3  A composition comprising a serotonin (5-HT)\\rr...  \n",
       " 4  Halogenated psilocybin derivative compounds\\rp...  \n",
       " 5  Hydroxylated psilocybin derivative compounds\\r...  ,\n",
       "     #                                              Title  \\\n",
       " 0  68  Glycosylated psilocybin derivatives and method...   \n",
       " 1  69  Biosynthesis and method of production of psilo...   \n",
       " 2  70  Novel psilocin derivatives having prodrug prop...   \n",
       " 3  71  Tailored hypoimmune nanovesicular delivery sys...   \n",
       " 4  72  Central nervous system delivery of nonsteroida...   \n",
       " 5  73      Central nervous system delivery of psilocybin   \n",
       " 6  74  Extended release 5-ht receptor agonists for ne...   \n",
       " \n",
       "                                     Owner/Assignee  Patent/Pub. No.  \\\n",
       " 0                              Enveric Biosciences     WO2022040802   \n",
       " 1                                   Synbionik Gmbh     EP 3957726A1   \n",
       " 2                               Compass Pathfinder     WO2022038299   \n",
       " 3  Thomas Malcolm;\\rSafia Rizvi; Surya\\rSankuratri  US20220040106A1   \n",
       " 4                                      Silo Pharma   WO2022031552A1   \n",
       " 5                                      Silo Pharma   WO2022031551A1   \n",
       " 6                            Diamond\\rTherapeutics   WO2022023812A1   \n",
       " \n",
       "   Priority Date     Status                             General Subject Matter  \n",
       " 0     26/8/2020  Published  Novel glycosylated psilocybin derivative compo...  \n",
       " 1     21/8/2020  Published  Biosynthetic methods of production of psilocin...  \n",
       " 2     21/8/2020  Published  Novel Psilocin derivatives that exhibit improv...  \n",
       " 3      5/8/2020  Published  Compositions of biomimetic nanovesicles (Hypo-...  \n",
       " 4      3/8/2020  Published  Treating a disease using a central nervous sys...  \n",
       " 5      3/8/2020  Published  Treating a disease using a central nervous sys...  \n",
       " 6     29/7/2020    Pending  Methods and compositions for treating or manag...  ,\n",
       "     #                                              Title  \\\n",
       " 0  75  Compositions and methods for treatment of psyc...   \n",
       " 1  76  Method of treatment for psilocybin or psilocin...   \n",
       " 2  77  Methods and systems for providing a personaliz...   \n",
       " 3  78  Compositions comprising psychoactive compounds...   \n",
       " 4  79  Extraction of psychoactive compounds from psil...   \n",
       " 5  80  Methanol-based extraction of psychoactive comp...   \n",
       " 6  81  Methods and compositions comprising psychoacti...   \n",
       " \n",
       "                                    Owner/Assignee  Patent/Pub. No.  \\\n",
       " 0  Stephen Barnhill; Ai\\rPharmaceuticals\\rJamaica     WO2022018709   \n",
       " 1                                         Eleusis   WO2022011350A1   \n",
       " 2                                    Greenway DNA    US20210407643   \n",
       " 3                                Psilo Scientific   WO2021253116A1   \n",
       " 4                                Psilo Scientific   WO2021253123A1   \n",
       " 5                                Psilo Scientific   WO2021253124A1   \n",
       " 6                                Psilo Scientific  US20210393716A1   \n",
       " \n",
       "   Priority Date     Status                             General Subject Matter  \n",
       " 0     21/7/2020  Published  Compositions of at least one serotonergic psyc...  \n",
       " 1     10/7/2020  Published  Iv administration of psilocybin or psilocin th...  \n",
       " 2     25/6/2020  Published  Methods and systems for providing a personaliz...  \n",
       " 3     17/6/2020  Published  A method for generating a psychoactive alkaloi...  \n",
       " 4     17/6/2020  Published  The solvent used for extraction is a lower ali...  \n",
       " 5     17/6/2020  Published  The solvent used for extraction is methanol or...  \n",
       " 6     17/6/2020  Published  A method for generating a psychoactive alkaloi...  ,\n",
       "     #                                              Title    Owner/Assignee  \\\n",
       " 0  82  Aqueous extraction of psychoactive compounds f...  Psilo Scientific   \n",
       " 1  83  Extraction of psychoactive compounds from psil...  Psilo Scientific   \n",
       " 2  84  Methods and compositions comprising psychoacti...  Psilo Scientific   \n",
       " 3  85  Methods and compositions comprising psychoacti...  Psilo Scientific   \n",
       " \n",
       "    Patent/Pub. No. Priority Date                                    Status  \\\n",
       " 0    US20220202886     17/6/2020                                 Published   \n",
       " 1       CA3088384C     17/6/2020  Granted 2021-08-03\\r(expires 2040-07-29)   \n",
       " 2  US20210393717A1     17/6/2020                                 Published   \n",
       " 3    US20220152136     17/6/2020                                 Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  This invention relates to the extraction of ps...  \n",
       " 1  This invention relates to the extraction of ps...  \n",
       " 2  A method for generating a psychoactive alkaloi...  \n",
       " 3  This invention relates to the extraction of ps...  ,\n",
       "     #                                              Title    Owner/Assignee  \\\n",
       " 0  86  Psychoactive alkaloid extraction and compositi...  Psilo Scientific   \n",
       " 1  87  Methanol-based extraction of psychoactive alka...  Psilo Scientific   \n",
       " 2  88  Enzymes and regulatory proteins in tryptamine\\...   CB Therapeutics   \n",
       " \n",
       "   Patent/Pub. No. Priority Date     Status  \\\n",
       " 0   WO20220040246     17/6/2020  Published   \n",
       " 1   US20220305402     17/6/2020  Published   \n",
       " 2    WO2021248087      6/6/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  This invention relates to the extraction of ps...  \n",
       " 1  This invention relates to the extraction of ps...  \n",
       " 2  Non-naturally occurring nucleic acids comprisi...  ,\n",
       "     #                                              Title  \\\n",
       " 0  89                Method for weight loss with therapy   \n",
       " 1  90  Crystalline 4-hydroxy-n,n-di-n-propyltryptammo...   \n",
       " 2  91  Deuterated tryptamine derivatives and methods ...   \n",
       " 3  92  Novel compositions of matter and pharmaceutica...   \n",
       " 4  93  Transdermal drug delivery devices having psilo...   \n",
       " \n",
       "           Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0  Neonmind\\rBiosciences  WO2021243460A1      3/6/2020  Published   \n",
       " 1               CaaMTech  WO2021236759A1     20/5/2020  Published   \n",
       " 2              Cybin IRL   US20220119346     19/5/2020  Published   \n",
       " 3                Psilera  WO2021226416A1      8/5/2020  Published   \n",
       " 4          Zosano Pharma  WO2021222885A1      1/5/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Disclosed is a method of aiding in weight loss...  \n",
       " 1  4-Hydroxy-N,N-di-n-propyltryptamine, or 4-HO-D...  \n",
       " 2  The present disclosure is based at least in pa...  \n",
       " 3  Pharmaceutical formulations of indole compound...  \n",
       " 4  Compositions, devices, and methods using psilo...  ,\n",
       "     #                                              Title  \\\n",
       " 0  94  Use of psilocybin in the treatment of neurolog...   \n",
       " 1  95                            LSD dose identification   \n",
       " 2  96                            LSD dose identification   \n",
       " 3  97  Medicinal food products and methods for produc...   \n",
       " 4  98  Molecularly-initiated, experimentally-delivere...   \n",
       " \n",
       "                                   Owner/Assignee  Patent/Pub. No.  \\\n",
       " 0                            Revive Therapeutics   WO2021207824A1   \n",
       " 1   Matthias\\rLiechti/Universitätss\\rpital Basel   WO2021211358A1   \n",
       " 2   Matthias\\rLiechti/Universitätss\\rpital Basel  US20210315884A1   \n",
       " 3                                   Daniel Lilly    US20210392933   \n",
       " 4  The Regents of the\\rUniversity of\\rCalifornia     WO2021202730   \n",
       " \n",
       "   Priority Date     Status                             General Subject Matter  \n",
       " 0     17/4/2020  Published  Methods for the treatment of a brain injury or...  \n",
       " 1     13/4/2020  Published  Methods of dosing psychedelics at \"microdose,\\...  \n",
       " 2     13/4/2020  Published  A method of dosing and treating patients with ...  \n",
       " 3     10/4/2020  Published  A method for producing medicinal cannabinoids\\...  \n",
       " 4      1/4/2020  Published  Methods of providing a sensory environment to ...  ,\n",
       "      #                                              Title  \\\n",
       " 0   99                    Crystalline forms of psilacetin   \n",
       " 1  100  Psilocybin and psilocin containing composition...   \n",
       " 2  101                  Crystalline norpsilocin compounds   \n",
       " 3  102                 Crystalline psilacetin derivatives   \n",
       " 4  103  3-(2-(aminoethyl)-indol-4-ol derivatives, meth...   \n",
       " 5  104  Methods and systems for enhancing clinical saf...   \n",
       " 6  105  Method for obtaining an extract of a plant bio...   \n",
       " \n",
       "               Owner/Assignee  Patent/Pub. No. Priority Date  \\\n",
       " 0                   CaaMTech     US11,358,934     23/3/2020   \n",
       " 1         Orthogonal Thinker   WO2021188870A1     20/3/2020   \n",
       " 2                   CaaMTech   WO2021188812A1     19/3/2020   \n",
       " 3                   CaaMTech   WO2021188782A1     19/3/2020   \n",
       " 4  Bright Minds\\rBiosciences   WO2021179091A1     12/3/2020   \n",
       " 5  Eleusis Health\\rSolutions   WO2021183490A2      9/3/2020   \n",
       " 6        Cure Pharmaceutical  US20210275618A1      5/3/2020   \n",
       " \n",
       "                                      Status  \\\n",
       " 0  Granted 2022-06-14\\r(expires 2040-12-23)   \n",
       " 1                                 Published   \n",
       " 2                                 Published   \n",
       " 3                                 Published   \n",
       " 4                                 Published   \n",
       " 5                                 Published   \n",
       " 6                             Pending in US   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Crystalline forms of 4-acetoxy-N,N-\\rdimethylt...  \n",
       " 1  Compositions of psilocybin and/or psilocin and...  \n",
       " 2  Norpsilocin compounds (crystalline 4-HO-NMT\\rf...  \n",
       " 3  Crystalline 4-acetoxy-substituted versions of ...  \n",
       " 4  Psilocin analogs that possess 5-HT2A and/or 5-...  \n",
       " 5  Methods of enhancing the safety of a psychoact...  \n",
       " 6  Methods for obtaining an extract using a super...  ,\n",
       "      #                                              Title  \\\n",
       " 0  106  Cannabis treatment of insomnia, pain, and skin...   \n",
       " 1  107  Controlling effects after 5ht2a agonists admin...   \n",
       " 2  108                  Crystalline bis-miprocin fumarate   \n",
       " 3  109  Method for producing an extract of mushrooom a...   \n",
       " \n",
       "               Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0                 Alte Verde   US20220071946      3/3/2020  Published   \n",
       " 1  Universitätsspital\\rBasel  WO2021173273A1     28/2/2020  Published   \n",
       " 2                   Caamtech  WO2021173989A1     27/2/2020  Published   \n",
       " 3      Neonmind\\rBiosciences  WO2021159213A1     12/2/2020  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  A pharmaceutical composition for treating one ...  \n",
       " 1  Methods of psychotherapy and drug combinations...  \n",
       " 2  Compositions of crystalline forms of bis(4-hyd...  \n",
       " 3  Methods of manufacturing a mushroom extract,\\r...  ,\n",
       "      #                                              Title  \\\n",
       " 0  110       Psychedelic treatment for headache disorders   \n",
       " 1  111  Psilocin derivatives as serotonergic psychedel...   \n",
       " 2  112  3-pyrrolidine-indole derivatives as serotonerg...   \n",
       " 3  113  Psilocin derivatives as serotonergic psychedel...   \n",
       " 4  114  Psilocin derivatives as serotonergic psychedel...   \n",
       " 5  115  Psilocin derivatives as serotonergic psychedel...   \n",
       " \n",
       "                                       Owner/Assignee  Patent/Pub. No.  \\\n",
       " 0  Yale University, U.S.\\rDep't of Veterans\\rAffairs  US20210236523A1   \n",
       " 1                                     Mindset Pharma     WO2021155470   \n",
       " 2                                     Mindset Pharma     WO2021155467   \n",
       " 3                                     Mindset Pharma  US20220024956A1   \n",
       " 4                                     Mindset Pharma     WO2021155468   \n",
       " 5                                     Mindset Pharma     US11,427,604   \n",
       " \n",
       "   Priority Date                                    Status  \\\n",
       " 0      5/2/2020                             Pending in US   \n",
       " 1      4/2/2020                                 Published   \n",
       " 2      4/2/2020                                 Published   \n",
       " 3      4/2/2020                                 Published   \n",
       " 4      4/2/2020                                 Published   \n",
       " 5      4/2/2020  Granted 2022-08-30\\r(expires 2041-02-04)   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Treating a headache disorder by administering\\...  \n",
       " 1  Prodrugs and deuterated derivatives of psilocy...  \n",
       " 2  3-pyrrolidine-indole derivatives of psilocybin...  \n",
       " 3  Psilocin derivatives to processes for their pr...  \n",
       " 4  Prodrugs and deuterated derivatives of psilocy...  \n",
       " 5  The present application relates to psilocin de...  ,\n",
       "      #                                              Title  \\\n",
       " 0  116  3-pyrrolidine-indole derivatives as serotonerg...   \n",
       " 1  117  Complexes comprising a carbohydrate polymer an...   \n",
       " 2  118  Use of psilocin, psilocybin or analogs thereof...   \n",
       " 3  119  Tryptamine compositions for enhancing neurite\\...   \n",
       " 4  120  Tryptamine compositions for enhancing neurite\\...   \n",
       " 5  121  Tryptamine compositions for enhancing neurite\\...   \n",
       " 6  122  Tryptamine compositions for enhancing neurite\\...   \n",
       " \n",
       "           Owner/Assignee  Patent/Pub. No. Priority Date              Status  \\\n",
       " 0         Mindset Pharma     US11,453,689      4/2/2020  Granted 2022-09-27   \n",
       " 1            Folium Labs   WO2021113986A1    13/12/2019           Published   \n",
       " 2  Neonmind\\rBiosciences   WO2021108911A1     4/12/2019       Pending in US   \n",
       " 3   Turtle Bear Holdings    US20220160737    19/11/2019           Published   \n",
       " 4   Turtle Bear Holdings    US20220125809    19/11/2019           Published   \n",
       " 5   Turtle Bear Holdings  US20210145851A1    19/11/2019       Pending in US   \n",
       " 6   Turtle Bear Holdings   WO2021101926A1    19/11/2019           Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  The present application relates to 3-cyclic am...  \n",
       " 1  \"Stabilized molecular complexes\" and compositi...  \n",
       " 2  Methods of aiding weight loss, treating compul...  \n",
       " 3  Nootropic or neurotrophic compositions for use...  \n",
       " 4  Nootropic or neurotrophic compositions for use...  \n",
       " 5  Neurotrophic and nootropic compositions compri...  \n",
       " 6  Neurotrophic and nootropic compositions and\\rm...  ,\n",
       "      #                                              Title  \\\n",
       " 0  123  Biosynthetic production of psilocybin and rela...   \n",
       " 1  124  Methods for the production of psilocybin and\\r...   \n",
       " 2  125  Compositions comprising superfine compounds an...   \n",
       " 3  126                 Stimulation of neuronal plasticity   \n",
       " 4  127  Controlled release formulations of psilocybe-d...   \n",
       " 5  128  Flavored bioactive extracts and methods of fla...   \n",
       " \n",
       "                                   Owner/Assignee  Patent/Pub. No.  \\\n",
       " 0                                CB Therapeutics     US11,441,164   \n",
       " 1                               Miami University   WO2021086513A1   \n",
       " 2                                        Esolate   WO2021081138A1   \n",
       " 3  Institute Of Science\\rAnd Technology\\rAustria   WO2021074448A1   \n",
       " 4    Tassili Life Sciences\\r(Champignon\\rBrands)   WO2021072530A1   \n",
       " 5                              Pure Laboratories  US20210100741A1   \n",
       " \n",
       "   Priority Date                                    Status  \\\n",
       " 0    15/11/2019  Granted 2022-09-13\\r(expires 2040-11-16)   \n",
       " 1    28/10/2019                                 Published   \n",
       " 2    21/10/2019                                 Published   \n",
       " 3    18/10/2019                                 Published   \n",
       " 4    15/10/2019                                 Published   \n",
       " 5     4/10/2019                             Pending in US   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  The systems and methods herein include enginee...  \n",
       " 1  Biosynthetic methods, prokaryotic (bacterial) ...  \n",
       " 2  Stable edible, inhalable, soluble, and drinkab...  \n",
       " 3  Inducing synchronized gamma oscillations by ap...  \n",
       " 4  Controlled release formulations of psilocybin ...  \n",
       " 5  Methods of formulating a homogeneous flavored\\...  ,\n",
       "      #                                              Title  \\\n",
       " 0  129  Genetic engineering of fungi to modulate trypt...   \n",
       " 1  130  Genetic engineering of fungi to modulate trypt...   \n",
       " 2  131  Yeast cells and methods for production of tryp...   \n",
       " 3  132  Alkyl quaternary ammonium tryptamines and thei...   \n",
       " 4  133  Methods of treating psychological and brain di...   \n",
       " 5  134  Methods of treating psychological and brain di...   \n",
       " \n",
       "                    Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0          Empyrean\\rNeuroscience  WO2021067626A1     1/10/2019  Published   \n",
       " 1          Empyrean\\rNeuroscience   US20220306997     1/10/2019  Published   \n",
       " 2  Danmarks Tekniske\\rUniversitet  WO2021052989A1     16/9/2019  Published   \n",
       " 3                        CaaMTech   US20220112162     25/8/2019  Published   \n",
       " 4         University of\\rMaryland  WO2021030571A1     13/8/2019  Published   \n",
       " 5         University of\\rMaryland   US20220273680     13/8/2019  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Methods for modulating the psilocybin biosynth...  \n",
       " 1  Provided herein are methods for modulating the...  \n",
       " 2  Transformed cells capable of producing compoun...  \n",
       " 3  This disclosure relates to alkyl quaternary am...  \n",
       " 4  Methods of treating a psychological disorder b...  \n",
       " 5  Provided herein are methods for preventing or\\...  ,\n",
       "      #                                              Title  \\\n",
       " 0  135  Controlled release formulations of multiple ac...   \n",
       " 1  136   Compositions containing toad secretion compounds   \n",
       " 2  137  Oral soft gel capsule containing psychedelic c...   \n",
       " \n",
       "                                 Owner/Assignee  Patent/Pub. No. Priority Date  \\\n",
       " 0  Tassili Life Sciences\\r(Champignon\\rBrands)     WO2021016710     30/7/2019   \n",
       " 1                                     CaaMTech    US20220273620     23/7/2019   \n",
       " 2                    Concept Matrix\\rSolutions  US20210015833A1     18/7/2019   \n",
       " \n",
       "           Status                             General Subject Matter  \n",
       " 0      Published  Psilocybe and cannabis derived compounds\\rform...  \n",
       " 1      Published  Disclosed are compositions containing two puri...  \n",
       " 2  Pending in US  Softgels containing “psilocybin, psilocin, bae...  ,\n",
       "      #                                              Title  \\\n",
       " 0  138  Oral dissolvable film containing psychedelic c...   \n",
       " 1  139                            Cannabinoid derivatives   \n",
       " 2  140  Metered dosing compositions and methods of use...   \n",
       " 3  141                            Cannabinoid derivatives   \n",
       " 4  142                              Ibogaine formulations   \n",
       " \n",
       "               Owner/Assignee  Patent/Pub. No. Priority Date         Status  \\\n",
       " 0  Concept Matrix\\rSolutions  US20210015738A1     17/7/2019  Pending in US   \n",
       " 1         Canopy Growth Corp    US20220259221     12/7/2019      Published   \n",
       " 2                SW Holdings   WO2021003467A1      4/7/2019      Published   \n",
       " 3         Canopy Growth Corp    US20220267239      4/7/2019      Published   \n",
       " 4                   CaamTech   WO2020263941A1     24/6/2019      Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Films containing “psilocybin, psilocin, baeocy...  \n",
       " 1  This disclosure relates to a cannabinoid deriv...  \n",
       " 2  Compositions of psychedelic compounds for use ...  \n",
       " 3  The present invention provides cannabinoid\\rde...  \n",
       " 4  New compositions and methods comprising a\\rcom...  ,\n",
       "      #                                              Title  \\\n",
       " 0  143  Process for making aqueous therapeutic particl...   \n",
       " 1  144  Methods of treating neurocognitive disorders, ...   \n",
       " 2  145  Treatment of depression and other various diso...   \n",
       " 3  146  Method for treating anxiety disorders, headach...   \n",
       " 4  147  Methods of treating neurocognitive disorders, ...   \n",
       " 5  148  Methods for treating anxiety disorders, headac...   \n",
       " \n",
       "                                 Owner/Assignee  Patent/Pub. No. Priority Date  \\\n",
       " 0  Karl Dresdner,\\rMichael Cary, Chase\\rHudson  US20200345585A1     30/4/2019   \n",
       " 1                      Compass Pathfinder\\rLtd    US20220169668     17/4/2019   \n",
       " 2                      Compass Pathfinder\\rLtd   WO2020212952A1     17/4/2019   \n",
       " 3                      Compass Pathfinder\\rLtd  US20220088041A1     17/4/2019   \n",
       " 4                      Compass Pathfinder\\rLtd   WO2020212948A1     17/4/2019   \n",
       " 5                      Compass Pathfinder\\rLtd   WO2020212951A1     17/4/2019   \n",
       " \n",
       "           Status                             General Subject Matter  \n",
       " 0  Pending in US  Processes for making aqueous therapeutic\\rnano...  \n",
       " 1      Published  The disclosure provides methods for treating a...  \n",
       " 2      Published  Treating depression, bipolar disorder, neuroco...  \n",
       " 3      Published  The disclosure provides methods for treating a...  \n",
       " 4      Published  Treating neurocognitive disorders, Parkinsonia...  \n",
       " 5      Published  Treating anxiety disorders, OCD, headache diso...  ,\n",
       "      #                                              Title  \\\n",
       " 0  149  Compositions and methods for modulating lipid ...   \n",
       " 1  150  Compositions and methods of use comprising\\rsu...   \n",
       " 2  151  Compositions and methods of use comprising\\rsu...   \n",
       " 3  152  Methods and compositions comprising a 5ht rece...   \n",
       " 4  153  Methods and compositions comprising a 5ht rece...   \n",
       " 5  154  Systems and methods of mitigating negative eff...   \n",
       " 6  155        Methods of treating food allergy conditions   \n",
       " \n",
       "                                   Owner/Assignee Patent/Pub. No.  \\\n",
       " 0  The Regents Of The\\rUniversity Of\\rCalifornia  WO2020185581A2   \n",
       " 1                                     Abormentis  WO2020181194A1   \n",
       " 2                                     Abormentis   US20220143051   \n",
       " 3                          Diamond\\rTherapeutics   US20220096504   \n",
       " 4                          Diamond\\rTherapeutics  WO2020157569A1   \n",
       " 5                            Apollo Neuroscience    US10,974,020   \n",
       " 6                            Palo Alto Investors  US11,045,454B2   \n",
       " \n",
       "   Priority Date                                    Status  \\\n",
       " 0      8/3/2019                                 Published   \n",
       " 1      7/3/2019                                 Published   \n",
       " 2      7/3/2019                                 Published   \n",
       " 3     30/1/2019                                 Published   \n",
       " 4     30/1/2019                                 Published   \n",
       " 5      4/1/2019  Granted 2021-04-13\\r(expires 2039-12-20)   \n",
       " 6     6/12/2018                          Granted 2021-6-9   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Promoting colonization of spore-forming bacter...  \n",
       " 1  Structural analogs of psilocin, norpsilocin, p...  \n",
       " 2  Structural analogs of psilocin, norpsilocin, p...  \n",
       " 3  Provided herein are methods and compositions f...  \n",
       " 4  Treating a neurological condition by administr...  \n",
       " 5  Transcutaneous vibratory simulation during psi...  \n",
       " 6  Methods for treating a subject for a food alle...  ,\n",
       "      #                                              Title  \\\n",
       " 0  156  Combination therapy for treating or preventing...   \n",
       " 1  157              Methods for inhibiting microbe growth   \n",
       " 2  158  Taar receptor agonists for the treatment of al...   \n",
       " 3  159  Method of inducing dendritic and synaptic gene...   \n",
       " 4  160  Method of inducing dendritic and synaptic gene...   \n",
       " 5  161              Heterologous production of psilocybin   \n",
       " 6  162        Processes for the production of tryptamines   \n",
       " \n",
       "                                       Owner/Assignee  Patent/Pub. No.  \\\n",
       " 0  Yale University, U.S.\\rDep't of Veterans\\rAffairs  US20210251969A1   \n",
       " 1                                Mcmaster University     US11,400,106   \n",
       " 2                                    Applied Biology   WO2020023084A1   \n",
       " 3                                   Robert Petcavich   WO2019246532A1   \n",
       " 4                             Robert John\\rPetcavich   WO2019246532A1   \n",
       " 5         VTT Technical\\rResearch Centre of\\rFinland  US20210010015A1   \n",
       " 6                         New Atlas\\rBiotechnologies    US20210277433   \n",
       " \n",
       "   Priority Date                                    Status  \\\n",
       " 0     20/8/2018                             Pending in US   \n",
       " 1      1/8/2018  Granted 2022-08-02\\r(expires 2039-08-01)   \n",
       " 2     26/7/2018                                 Published   \n",
       " 3     21/6/2018                                 Published   \n",
       " 4     21/6/2018                                 Published   \n",
       " 5     19/3/2018                             Pending in US   \n",
       " 6      8/3/2018                             Pending in US   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Treating depression and mood disorders, with\\r...  \n",
       " 1  Provided herein are methods and compositions u...  \n",
       " 2  Methods for treating hair shedding by applying...  \n",
       " 3  Treating neurodegenerative disease by administ...  \n",
       " 4  Methods to recover and restore dendritic and s...  \n",
       " 5  Biosynthetic production of psilocybin from hos...  \n",
       " 6  Tryptamine and ibogamine compounds,\\rpharmaceu...  ,\n",
       "      #                                              Title  \\\n",
       " 0  163        Processes for the production of tryptamines   \n",
       " 1  164  Cognitive platform including computerized elem...   \n",
       " 2  165  Compositions comprising a psilocybin derivativ...   \n",
       " 3  166  Combination product for the treatment of neuro...   \n",
       " 4  167  Methods and systems for enhancing safety of\\rp...   \n",
       " 5  168  Preparation of psilocybin, different polymorph...   \n",
       " 6  169  Preparation of psilocybin, different polymorph...   \n",
       " 7  170  Preparation of psilocybin, different polymorph...   \n",
       " \n",
       "                                       Owner/Assignee  Patent/Pub. No.  \\\n",
       " 0                         New Atlas\\rBiotechnologies  US20210108238A1   \n",
       " 1                                  Akili Interactive     WO2019161050   \n",
       " 2                                           CaaMTech  US20190142851A1   \n",
       " 3  Consejo Superior De\\rInvestigaciones\\rCientífi...   WO2019081764A1   \n",
       " 4                               Eleusis Benefit Corp   WO2019079742A1   \n",
       " 5                                   Compass Pathways     US10,947,257   \n",
       " 6                                   Compass Pathways     US10,947,257   \n",
       " 7                            Compass Pathfinder\\rLtd   US11,149,044B2   \n",
       " \n",
       "   Priority Date                                    Status  \\\n",
       " 0      8/3/2018                             Pending in US   \n",
       " 1     18/2/2018                                 Published   \n",
       " 2    16/11/2017                             Pending in US   \n",
       " 3    26/10/2017                                 Published   \n",
       " 4    19/10/2017                                 Published   \n",
       " 5     9/10/2017  Granted 2021-03-23\\r(expires 2038-10-09)   \n",
       " 6     9/10/2017  Granted 2021-03-16\\r(expires 2038-10-09)   \n",
       " 7     9/10/2017  Granted 2021-10-19\\r(expires 2038-12-11)   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Prokaryotic and eukaryotic microbes, including...  \n",
       " 1  Computer systems for mood and cognitive assess...  \n",
       " 2  Purified psilocybin derivatives combined with ...  \n",
       " 3  Combination product comprising (1) psychedelic...  \n",
       " 4  Screening a candidate for treatment with a psy...  \n",
       " 5  Oral dosage forms of crystalline psilocybin in...  \n",
       " 6  Pharmaceutical compositions of crystalline psi...  \n",
       " 7  The large-scale production of psilocybin for u...  ,\n",
       "      #                                              Title  \\\n",
       " 0  171  Preparation of psilocybin, different polymorph...   \n",
       " 1  172  Preparation of psilocybin, different polymorph...   \n",
       " 2  173  Preparation of psilocybin, different polymorph...   \n",
       " 3  174  Preparation of psilocybin, different polymorph...   \n",
       " 4  175  Use of cannabidiol in combination with 5-ht2b ...   \n",
       " 5  176  Use of cannabidiol in combination with 5-ht2b ...   \n",
       " 6  177  Use of cannibidiol in combination with 5-ht2b ...   \n",
       " \n",
       "                 Owner/Assignee Patent/Pub. No. Priority Date  \\\n",
       " 0           Compass Pathfinder  US11,180,517B2     9/10/2017   \n",
       " 1             Compass Pathways  US11,505,564B2     9/10/2017   \n",
       " 2             Compass Pathways  US10,519,175B2     9/10/2017   \n",
       " 3  Compass Pathfinder\\rLimited  US11,447,510B2     9/10/2017   \n",
       " 4                  GW Research   US20200237683     29/9/2017   \n",
       " 5                  GW Research   US20200237683     29/9/2017   \n",
       " 6                  GW Research  WO2019064031A1     29/9/2017   \n",
       " \n",
       "                                      Status  \\\n",
       " 0  Granted 2021-11-23\\r(expires 2038-10-09)   \n",
       " 1                        Granted 2022-11-22   \n",
       " 2  Granted 2019-12-31\\r(expires 2038-10-09)   \n",
       " 3  Granted 2022-09-20\\r(expires 2038-12-11)   \n",
       " 4                             Pending in US   \n",
       " 5                                 Published   \n",
       " 6                                 Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  The large-scale production of psilocybin for u...  \n",
       " 1  Methods for manufacturing psilocybin from psil...  \n",
       " 2  Treating drug resistant depression with crysta...  \n",
       " 3  This invention relates to the large-scale prod...  \n",
       " 4  CBD in combination with a 5-HT2B receptor agon...  \n",
       " 5  Treatments for epilepsy using CBD in combinati...  \n",
       " 6  Methods of treating epileptic seizures using a...  ,\n",
       "      #                                              Title  \\\n",
       " 0  178  Use of cannabidiol in combination with 5-HT2B ...   \n",
       " \n",
       "          Owner/Assignee Patent/Pub. No. Priority Date     Status  \\\n",
       " 0  GW Research\\rLimited    US11,419,829     29/9/2017  Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  The present invention relates to the use of ca...  ,\n",
       "      #                                              Title  \\\n",
       " 0  179  Liquid dispensing system creating and maintain...   \n",
       " 1  180  Liquid dispensing system creating and maintain...   \n",
       " 2  181  Compositions and methods for treating ocular\\r...   \n",
       " 3  182  Assessing and treating psychedelic-responsive ...   \n",
       " 4  183  Assessing and treating psychedelic-responsive ...   \n",
       " \n",
       "                         Owner/Assignee  Patent/Pub. No. Priority Date  \\\n",
       " 0         Sensory Design &\\rTechnology  US20200211703A1     29/7/2017   \n",
       " 1         Sensory Design &\\rTechnology     WO2019025763     29/7/2017   \n",
       " 2  Timothy Foster and\\rCharles Nichols  US20200330405A1      1/5/2017   \n",
       " 3                          Eleusis PBC    US20200147038     20/4/2017   \n",
       " 4                          Eleusis PBC     WO2018195455     20/4/2017   \n",
       " \n",
       "           Status                             General Subject Matter  \n",
       " 0  Pending in US  Wearable devices that dispense controllable vo...  \n",
       " 1      Published  Methods and devices for \"creating and maintain...  \n",
       " 2  Pending in US  Methods of treating an eye condition using a\\r...  \n",
       " 3  Pending in US  Improving mental or physical well-being by\\rad...  \n",
       " 4      Published  Methods of identifying a subject as being like...  ,\n",
       "      #                                              Title Owner/Assignee  \\\n",
       " 0  184  Compositions comprising a serotonergic tryptam...       CaaMTech   \n",
       " 1  185  Compositions and methods comprising a psilocyb...       CaaMTech   \n",
       " 2  186  Compositions and methods comprising a combinat...       CaaMTech   \n",
       " 3  187  Compositions comprising a serotonergic tryptam...       CaaMTech   \n",
       " 4  188  Compositions and methods comprising a psilocyb...       CaaMTech   \n",
       " \n",
       "    Patent/Pub. No. Priority Date                                    Status  \\\n",
       " 0  US20210346346A1      9/2/2017                                 Published   \n",
       " 1   US10,933,073B2      9/2/2017  Granted 2021-03-02\\r(expires 2038-09-11)   \n",
       " 2  US20210085671A1      9/2/2017                             Pending in US   \n",
       " 3  US20210361679A1      9/2/2017                                 Published   \n",
       " 4   WO2018148605A1      9/2/2017                                 Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Compositions comprising a serotonergic tryptam...  \n",
       " 1  Dosage formulations comprising certain psilocy...  \n",
       " 2  Combinations of two serotonergic drugs, includ...  \n",
       " 3  A serotonergic tryptamine compound, combinatio...  \n",
       " 4  Methods of modulating activity at a neurotrans...  ,\n",
       "      #                                              Title  \\\n",
       " 0  189  Compositions and methods comprising a combinat...   \n",
       " 1  190  Compositions and methods comprising a combinat...   \n",
       " 2  191  Psilocybin and/or psilocin in combination with...   \n",
       " 3  192  Method for treatment of depression using synap...   \n",
       " 4  193        Biosynthetic cannabinoid production methods   \n",
       " 5  194                      Cannabis nanoemulsion methods   \n",
       " 6  195   Compositions and methods for treating depression   \n",
       " \n",
       "          Owner/Assignee  Patent/Pub. No. Priority Date  \\\n",
       " 0              CaaMTech   US202117388252      9/2/2017   \n",
       " 1              CaaMTech   US202017095430      9/2/2017   \n",
       " 2        Procare Beheer   US10,729,706B2     18/1/2017   \n",
       " 3        Joseph Rustick   US10,596,378B2    18/10/2016   \n",
       " 4            Insectergy   US11,180,781B2     21/8/2016   \n",
       " 5            Insectergy   US10,738,268B2     21/8/2016   \n",
       " 6  Turtle Bear Holdings  US20220016104A1     23/7/2016   \n",
       " \n",
       "                                      Status  \\\n",
       " 0                                 Published   \n",
       " 1                             Pending in US   \n",
       " 2  Granted 2020-08-04\\r(expires 2038-01-18)   \n",
       " 3  Granted 2020-03-24\\r(expires 2038-06-07)   \n",
       " 4  Granted 2021-11-23\\r(expires 2036-08-21)   \n",
       " 5  Granted 2020-08-11\\r(expires 2036-11-01)   \n",
       " 6                                 Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Compositions and methods of a first serotonerg...  \n",
       " 1  Compositions and methods of a first serotonerg...  \n",
       " 2  Treating a psychological disorder by administr...  \n",
       " 3  Treating a neurologic condition by synaptic pa...  \n",
       " 4  Distilled compositions comprising a mixture of...  \n",
       " 5  Methods to produce cannabis oil nanoemulsions ...  \n",
       " 6  Methods and compositions for enhancing\\rneurog...  ,\n",
       "      #                                              Title  \\\n",
       " 0  196  Compositions and methods for enhancing\\rneuror...   \n",
       " 1  197                            Psilocybin compositions   \n",
       " 2  198             Compositions of psilocybin and analogs   \n",
       " 3  199  Tryptamine compositions for enhancing neurite\\...   \n",
       " 4  200                            Psilocybin compositions   \n",
       " 5  201  Tryptamine compositions for enhancing neurite\\...   \n",
       " 6  202                            Psilocybin Compositions   \n",
       " \n",
       "          Owner/Assignee  Patent/Pub. No. Priority Date         Status  \\\n",
       " 0          Paul Stamets  US20180021326A1     23/7/2016      Abandoned   \n",
       " 1  Turtle Bear Holdings  US20190105313A1     23/7/2016  Pending in US   \n",
       " 2          Paul Stamets    US20200375967     23/7/2016  Pending in US   \n",
       " 3  Turtle Bear Holdings  US20210251976A1     23/7/2016  Pending in US   \n",
       " 4  Turtle Bear Holdings  US20190192498A1     23/7/2016  Pending in US   \n",
       " 5  Turtle Bear Holdings  US20210069170A1     23/7/2016  Pending in US   \n",
       " 6  Turtle Bear Holdings  US20220313674A1     23/7/2016      Published   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Compositions of psilocybin, niacin, and mushro...  \n",
       " 1  Compositions of psilocybin, niacin, and mushro...  \n",
       " 2  Compositions of psilocybin, niacin, and mushro...  \n",
       " 3  Methods of treating or improving a mental heal...  \n",
       " 4  Compositions of psilocybin, niacin, and mushro...  \n",
       " 5  Neurotrophic and nootropic compositions compri...  \n",
       " 6  Methods and compositions are disclosed for\\ren...  ,\n",
       "      #                                              Title  \\\n",
       " 0  203                   Orally administrable composition   \n",
       " 1  204      Personal vaporizing device with slidable cart   \n",
       " 2  205                     Flow regulating inhaler device   \n",
       " 3  206          Drug dose cartridge for an inhaler device   \n",
       " 4  207                        Pharmaceutical compositions   \n",
       " 5  208   Integrative fungal solutions for protecting bees   \n",
       " 6  209  Methods, apparatuses and systems for transcran...   \n",
       " \n",
       "                                       Owner/Assignee  Patent/Pub. No.  \\\n",
       " 0                                         CTT Pharma    US20220079881   \n",
       " 1                                       Syqe Medical     US11,229,758   \n",
       " 2                                       Syqe Medical     US10,166,349   \n",
       " 3                                       Syqe Medical     US11,160,937   \n",
       " 4                           Charleston\\rLaboratories   WO2015157738A1   \n",
       " 5                                       Paul Stamets  US20200376055A1   \n",
       " 6  The University of\\rNorth Carolina at\\rChapel Hill   US10,188,342B2   \n",
       " \n",
       "   Priority Date              Status  \\\n",
       " 0      3/3/2016           Published   \n",
       " 1     11/1/2016  Granted 2022-01-25   \n",
       " 2     30/6/2014  Granted 2019-01-01   \n",
       " 3     30/6/2014  Granted 2021-11-02   \n",
       " 4     10/4/2014           Published   \n",
       " 5     10/3/2014       Pending in US   \n",
       " 6     5/11/2013  Granted 2019-01-29   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  An orally administrable micellar composition i...  \n",
       " 1  A device for delivering an active substance th...  \n",
       " 2  An inhaler device for pulmonary delivery of at...  \n",
       " 3  Devices and methods are described for preparin...  \n",
       " 4  Compositions of substances, including ibogaine...  \n",
       " 5  Compositions for improving bee health and for\\...  \n",
       " 6  Methods of transcranial stimulation, including...  ,\n",
       "      #                                              Title  \\\n",
       " 0  210                Method and system for drug delivery   \n",
       " 1  211                Method and system for drug delivery   \n",
       " 2  212          Methods of improving behavioral therapies   \n",
       " 3  213  Pharmaceutical compositions for treating or pr...   \n",
       " 4  214  Compositions and methods for evaluating cognit...   \n",
       " 5  215  Composition for transdermal delivery of cation...   \n",
       " 6  216  Salts of physiologically active and psychoacti...   \n",
       " 7  217  Opioid and attention deficit hyperactivity dis...   \n",
       " 8  218            Safety of pseudoephedrine drug products   \n",
       " \n",
       "                            Owner/Assignee  Patent/Pub. No. Priority Date  \\\n",
       " 0                            Syqe Medical   US11,071,712B2    22/12/2010   \n",
       " 1                            Syqe Medical    US9,775,379B2    22/12/2010   \n",
       " 2                        Emory University  US20120108510A1     20/5/2010   \n",
       " 3  Locl Pharma;\\rCharleston\\rLaboratories     US10,532,030      8/7/2009   \n",
       " 4                            Galenea Corp  US20120159656A1     24/4/2009   \n",
       " 5     LTS Lohmann\\rTherapie Systeme\\rGmbH   US10,881,607B2     19/6/2008   \n",
       " 6                             Pisgah Labs  US20080293695A1     22/5/2007   \n",
       " 7                             Pisgah Labs     US10,183,001     22/5/2007   \n",
       " 8                             Pisgah Labs      US9,421,266     22/5/2007   \n",
       " \n",
       "                                      Status  \\\n",
       " 0  Granted 2021-07-27\\r(expires 2032-07-23)   \n",
       " 1  Granted 2017-10-03\\r(expires 2034-09-26)   \n",
       " 2                                 Abandoned   \n",
       " 3                        Granted 2020-01-14   \n",
       " 4                                 Abandoned   \n",
       " 5  Granted 2021-01-05\\r(expires 2029-06-16)   \n",
       " 6                                 Abandoned   \n",
       " 7  Granted 2019-01-22\\r(expires 2027-10-13)   \n",
       " 8                                   Expired   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Drug dose structure for use with an inhaler de...  \n",
       " 1  Inhaler device for controlled extraction of at...  \n",
       " 2  Psychedelic-assisted psychotherapy using an ox...  \n",
       " 3  Methods and compositions are provided which\\rc...  \n",
       " 4  Using psilocybin to identify a candidate thera...  \n",
       " 5  Transdermal patch with composition for transde...  \n",
       " 6  Drug substances that can be administered\\rther...  \n",
       " 7  Drug products with improved safety and anti-ab...  \n",
       " 8  Drug products with improved safety and anti-ab...  ,\n",
       "      #                                              Title  \\\n",
       " 0  219  Abuse deterrent and anti-dose dumping pharmace...   \n",
       " 1  220           Cannabinoid candy foodstuff compositions   \n",
       " 2  221  Modulation of secondary metabolite production ...   \n",
       " 3  222  Method of inducing therapeutic tranquilization...   \n",
       " 4  223                                  Esters of indoles   \n",
       " 5  224  Obtaining psilocybin and psilocin from fungal ...   \n",
       " \n",
       "                               Owner/Assignee Patent/Pub. No. Priority Date  \\\n",
       " 0                        Pisgah Laboratories   US9,226,925B1    10/11/2006   \n",
       " 1                                 Insectergy   US20220151980      3/7/2002   \n",
       " 2  Koninklijke DSM\\r(formerly Microbia\\rInc)   US7,229,784B2     19/9/2000   \n",
       " 3                                     Sandoz    US3,192,111A     16/2/1959   \n",
       " 4                                     Sandoz    US3,075,992A     12/9/1958   \n",
       " 5                                     Sandoz    US3,183,172A     21/2/1958   \n",
       " \n",
       "                                      Status  \\\n",
       " 0                        Granted 2016-01-05   \n",
       " 1                                 Published   \n",
       " 2  Granted 2007-06-12\\r(expires 2023-06-05)   \n",
       " 3  Granted 1965-06-29\\r(expired 1982-06-29)   \n",
       " 4  Granted 1963-01-29\\r(expired 1980-01-29)   \n",
       " 5  Granted 1965-05-11\\r(expired 1982-05-11)   \n",
       " \n",
       "                               General Subject Matter  \n",
       " 0  Pharmaceutical compositions which are particul...  \n",
       " 1  Cannabinoid candy foodstuff compositions are\\r...  \n",
       " 2  Improving yield of fungal metabolites in\\rbioe...  \n",
       " 3  Using psilocybin and psilocin to induce tranqu...  \n",
       " 4  Discloses, with coinventor Franz Troxler, the ...  \n",
       " 5  Extracting psilocybin and psilocin from fungal...  ]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tables"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "49"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(tables)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "dataframes=[]\n",
    "for table in tables:\n",
    "    df=pd.DataFrame(table)\n",
    "    dataframes.append(df)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "result=pd.concat(dataframes)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>#</th>\n",
       "      <th>Title</th>\n",
       "      <th>Owner/Assignee</th>\n",
       "      <th>Patent/Pub. No.</th>\n",
       "      <th>Priority Date</th>\n",
       "      <th>Status</th>\n",
       "      <th>General Subject Matter</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Method of treatment based on reduced monoamine...</td>\n",
       "      <td>Lennham\\rPharmaceuticals</td>\n",
       "      <td>US11,344,564</td>\n",
       "      <td>20/8/2021</td>\n",
       "      <td>Granted 2022-5-31\\r(expires 2041-12-17)</td>\n",
       "      <td>The method includes determining whether a subj...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>Methods of crossbreeding fungi organisms</td>\n",
       "      <td>Jerred Tudela</td>\n",
       "      <td>US11,419,280</td>\n",
       "      <td>23/7/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Methods of crossbreeding fungi organisms. The\\...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>Methods and compositions comprising psychoacti...</td>\n",
       "      <td>Psilo Scientific</td>\n",
       "      <td>US20220226405</td>\n",
       "      <td>14/6/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>This invention relates to the extraction of ps...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4</td>\n",
       "      <td>Methods and compositions relating to psychedel...</td>\n",
       "      <td>Terran Biosciences</td>\n",
       "      <td>WO2022212854</td>\n",
       "      <td>1/4/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Provided herein are compositions relating to\\r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5</td>\n",
       "      <td>Transdermal system, formulation, and method fo...</td>\n",
       "      <td>Mycrodose\\rtherapeutics inc.</td>\n",
       "      <td>WO2022212789</td>\n",
       "      <td>31/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>A drug delivery system is provided for transde...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>6</td>\n",
       "      <td>Artificial expression constructs for modulatin...</td>\n",
       "      <td>Allen institute</td>\n",
       "      <td>WO2022212585</td>\n",
       "      <td>30/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Artificial expression constructs for modulatin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>7</td>\n",
       "      <td>Psilocybin compositions, methods of making and...</td>\n",
       "      <td>Compass Pathfinder\\rLimited</td>\n",
       "      <td>WO2022207746</td>\n",
       "      <td>30/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>The present disclosure provides pharmaceutical...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>8</td>\n",
       "      <td>Use of psychedelics to treat dementia</td>\n",
       "      <td>Mynd Life Sciences</td>\n",
       "      <td>WO2022204802</td>\n",
       "      <td>30/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>The present invention provides use of psychede...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>9</td>\n",
       "      <td>Treatment protocol computer systems and methods</td>\n",
       "      <td>Mind Cure Health</td>\n",
       "      <td>WO2022204805</td>\n",
       "      <td>29/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Computer-implemented methods of treating at le...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>10</td>\n",
       "      <td>Psilocybin analogs, salts, compositions, and m...</td>\n",
       "      <td>Cybin IRL Limited</td>\n",
       "      <td>WO2022195011</td>\n",
       "      <td>18/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>The present disclosure relates to psilocin com...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>11</td>\n",
       "      <td>Improved methods for the use of psychedelics</td>\n",
       "      <td>Tryp Therapeutics</td>\n",
       "      <td>WO2022195489</td>\n",
       "      <td>15/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Provided are improved methods for treating a\\r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>12</td>\n",
       "      <td>Dosing regimens of pharmaceutical and nutraceu...</td>\n",
       "      <td>Allied Corp.</td>\n",
       "      <td>WO2022187973</td>\n",
       "      <td>12/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>The present invention discloses compositions f...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>13</td>\n",
       "      <td>5-HT receptor agonist titration</td>\n",
       "      <td>Diamond\\rTherapeutics</td>\n",
       "      <td>WO2022189855</td>\n",
       "      <td>8/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Disclosed herein are methods of treating\\rneur...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>14</td>\n",
       "      <td>Formulations of Psilocin that have enhanced st...</td>\n",
       "      <td>Mind Medicine</td>\n",
       "      <td>US20220280482</td>\n",
       "      <td>6/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>A composition of psilocin that is stable inclu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>15</td>\n",
       "      <td>Formulations of Psilocin that have enhanced st...</td>\n",
       "      <td>Mind Medicine</td>\n",
       "      <td>WO2022192097</td>\n",
       "      <td>6/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>A composition of psilocin that is stable inclu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>16</td>\n",
       "      <td>Synergistic cannabinoid esters, their salts an...</td>\n",
       "      <td>London\\rPharmaceuticals and\\rResearch\\rCorpora...</td>\n",
       "      <td>WO2022183292</td>\n",
       "      <td>3/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Cannabinoid esters and their soluble salts wit...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>17</td>\n",
       "      <td>Effects of lysergic acid diethylamide [lsd] an...</td>\n",
       "      <td>Universitatsspital\\rbasel</td>\n",
       "      <td>WO2022175821</td>\n",
       "      <td>19/2/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>A method of treating anxiety disorders specifi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>18</td>\n",
       "      <td>Effects of lysergic acid diethylamide (lsd) an...</td>\n",
       "      <td>Universitatsspital\\rBasel</td>\n",
       "      <td>US20220273628</td>\n",
       "      <td>19/2/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>A method of treating anxiety disorders specifi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>19</td>\n",
       "      <td>Multi-substituent psilocybin derivatives and m...</td>\n",
       "      <td>Enveric Biosciences</td>\n",
       "      <td>WO2022170438</td>\n",
       "      <td>12/2/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Disclosed are novel multi-substitute psilocybi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>20</td>\n",
       "      <td>Pharmaceutically acceptable salts of psilocin ...</td>\n",
       "      <td>Eleusis Therapeutics</td>\n",
       "      <td>WO2022173888</td>\n",
       "      <td>10/2/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>The present invention features pharmaceuticall...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>21</td>\n",
       "      <td>Methods of use and formulations of allosteric\\...</td>\n",
       "      <td>David Alan Heldreth,\\rJr.</td>\n",
       "      <td>US20220265601</td>\n",
       "      <td>10/2/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>The invention involves the use of formulations...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>22</td>\n",
       "      <td>Rapid method of producing non-alcoholic and al...</td>\n",
       "      <td>Ceria</td>\n",
       "      <td>WO2022165387</td>\n",
       "      <td>31/1/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>A rapid method of brewing malt beverages havin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>23</td>\n",
       "      <td>Rapid method of producing non-alcoholic and al...</td>\n",
       "      <td>Ceria</td>\n",
       "      <td>US11,521,444</td>\n",
       "      <td>31/1/2021</td>\n",
       "      <td>Granted 2022-12-06</td>\n",
       "      <td>A rapid method of brewing malt beverages havin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>24</td>\n",
       "      <td>Prenylated psilocybin derivatives and methods ...</td>\n",
       "      <td>Enveric Biosciences</td>\n",
       "      <td>WO2022155751</td>\n",
       "      <td>22/1/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Disclosed are novel prenylated psilocybin deri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>25</td>\n",
       "      <td>Activated cannabis products and methods for\\rp...</td>\n",
       "      <td>2655626 Ontario Inc.</td>\n",
       "      <td>WO2022155741</td>\n",
       "      <td>20/1/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>The present disclosure describes cannabis prod...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>26</td>\n",
       "      <td>Nanoparticle-mediated immune cell manufacture ...</td>\n",
       "      <td>The George\\rWashington\\rUniversity</td>\n",
       "      <td>WO2022150763</td>\n",
       "      <td>11/1/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>The present disclosure generally relates targe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>27</td>\n",
       "      <td>Systems and methods for pharmaceutical product...</td>\n",
       "      <td>Miami University</td>\n",
       "      <td>WO2022150854</td>\n",
       "      <td>11/1/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Provided are systems and methods for the produ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>28</td>\n",
       "      <td>Treatment of suicidality with psilocin or psil...</td>\n",
       "      <td>New York University</td>\n",
       "      <td>WO2022150563</td>\n",
       "      <td>8/1/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>The invention relates to a method of preventin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>29</td>\n",
       "      <td>Psilocybin and norbaeocystin compositions and\\...</td>\n",
       "      <td>Miami University</td>\n",
       "      <td>WO2022150840</td>\n",
       "      <td>8/1/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Provided is a pharmaceutical composition compr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>30</td>\n",
       "      <td>Protected alkyl tryptamines and their therapeu...</td>\n",
       "      <td>CaaMTech</td>\n",
       "      <td>WO2022150530</td>\n",
       "      <td>8/1/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>The disclosure relates to protected alkyl tryp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>31</td>\n",
       "      <td>Composition for treating opioid withdrawal and...</td>\n",
       "      <td>Mai Nguyen</td>\n",
       "      <td>US20220218649</td>\n",
       "      <td>7/1/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>A composition for treating opioid withdrawal a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>32</td>\n",
       "      <td>Vaporizable psychoactive alkaloid composition ...</td>\n",
       "      <td>Psilo Scientific</td>\n",
       "      <td>WO2022140846</td>\n",
       "      <td>28/12/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>This liquid composition includes a psychoactiv...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>33</td>\n",
       "      <td>Transmucosal psychoactive alkaloid composition...</td>\n",
       "      <td>Psilo Scientific</td>\n",
       "      <td>WO2022140841</td>\n",
       "      <td>28/12/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>A transmucosal psychoactive alkaloid compositi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>34</td>\n",
       "      <td>Vaporizable psychoactive alkaloid composition ...</td>\n",
       "      <td>Psilo Scientific</td>\n",
       "      <td>US20220313713</td>\n",
       "      <td>28/12/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>This liquid composition includes a psychoactiv...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>35</td>\n",
       "      <td>Transmucosal psychoactive alkaloid composition...</td>\n",
       "      <td>Psilo Scientific</td>\n",
       "      <td>US20220313762</td>\n",
       "      <td>28/12/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>A transmucosal psychoactive alkaloid compositi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>36</td>\n",
       "      <td>Compositions and methods for anxiety disorder\\...</td>\n",
       "      <td>Psilobrain\\rTherapeutics</td>\n",
       "      <td>WO2022137107</td>\n",
       "      <td>21/12/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>Composition consisting of psilocybin and croci...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>37</td>\n",
       "      <td>Use of psilocybin in cancer treatment</td>\n",
       "      <td>Silo Pharma</td>\n",
       "      <td>WO2022125949</td>\n",
       "      <td>13/12/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>Methods of treating and/or alleviating prolife...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>38</td>\n",
       "      <td>Dialkyl trytamines and their therapeutic uses</td>\n",
       "      <td>CaaMTech</td>\n",
       "      <td>WO2022125616</td>\n",
       "      <td>9/12/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>The disclosure relates to a composition compri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>39</td>\n",
       "      <td>Pharmaceutical composition comprising psilocyb...</td>\n",
       "      <td>Beckley Psytech</td>\n",
       "      <td>WO2022123232</td>\n",
       "      <td>7/12/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>A composition for use in a method of treatment...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>40</td>\n",
       "      <td>Aldehyde and ketone derivatives of psilocybin ...</td>\n",
       "      <td>Enveric Biosciences</td>\n",
       "      <td>WO2022115960</td>\n",
       "      <td>4/12/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>A chemical compound having the psilocybin mole...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>41</td>\n",
       "      <td>Novel psilocin analog compositions and methods...</td>\n",
       "      <td>Mydecine\\rInnovations</td>\n",
       "      <td>WO2022120181</td>\n",
       "      <td>3/12/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>Novel psilosin analogs exhibiting enhanced res...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>42</td>\n",
       "      <td>Carboxylated psilocybin derivatives and method...</td>\n",
       "      <td>Enveric Biosciences</td>\n",
       "      <td>WO2022115944</td>\n",
       "      <td>1/12/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>A chemical compound having the psilocybin mole...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>43</td>\n",
       "      <td>Compositions and methods for treating migraine</td>\n",
       "      <td>Wesana Health</td>\n",
       "      <td>WO2022115798</td>\n",
       "      <td>30/11/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>Disclosure features compositions containing\\rc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>44</td>\n",
       "      <td>Compositions and methods for treating neurolog...</td>\n",
       "      <td>Wesana Health</td>\n",
       "      <td>WO2022115796</td>\n",
       "      <td>30/11/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>Disclosure features compositions containing a\\...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>45</td>\n",
       "      <td>Treatment of anxiety and depression</td>\n",
       "      <td>New York University</td>\n",
       "      <td>US20220151993</td>\n",
       "      <td>16/11/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>Method of alleviating depression and/or anxiet...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>46</td>\n",
       "      <td>Engineered microorganisms for producing substi...</td>\n",
       "      <td>Algae-C</td>\n",
       "      <td>WO2022099424</td>\n",
       "      <td>16/11/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>Presented herein are microorganisms for produc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>47</td>\n",
       "      <td>Compositions and methods for extracting, stabi...</td>\n",
       "      <td>Richard C Kaufman</td>\n",
       "      <td>US20220054402</td>\n",
       "      <td>5/11/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>Invention discloses nano-dimensional compositi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>48</td>\n",
       "      <td>Thc beverage preparation apparatus and method ...</td>\n",
       "      <td>Cave; Mason; et al.</td>\n",
       "      <td>US20220125091</td>\n",
       "      <td>24/10/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>A method for preparing and packaging a THC\\rbe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>49</td>\n",
       "      <td>Cannabis time release apparatus and method of\\...</td>\n",
       "      <td>Hazen; Kevin; et al.</td>\n",
       "      <td>US20220125755</td>\n",
       "      <td>24/10/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>A method for forming a Cannabis product, compr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>50</td>\n",
       "      <td>Food / beverage nootropic amendment apparatus ...</td>\n",
       "      <td>Roth; Michael; et al.</td>\n",
       "      <td>US20220127058</td>\n",
       "      <td>24/10/2020</td>\n",
       "      <td>Published</td>\n",
       "      <td>The invention comprises a method and apparatus...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    #                                              Title  \\\n",
       "0   1  Method of treatment based on reduced monoamine...   \n",
       "1   2           Methods of crossbreeding fungi organisms   \n",
       "2   3  Methods and compositions comprising psychoacti...   \n",
       "0   4  Methods and compositions relating to psychedel...   \n",
       "1   5  Transdermal system, formulation, and method fo...   \n",
       "2   6  Artificial expression constructs for modulatin...   \n",
       "0   7  Psilocybin compositions, methods of making and...   \n",
       "1   8              Use of psychedelics to treat dementia   \n",
       "2   9    Treatment protocol computer systems and methods   \n",
       "3  10  Psilocybin analogs, salts, compositions, and m...   \n",
       "0  11       Improved methods for the use of psychedelics   \n",
       "1  12  Dosing regimens of pharmaceutical and nutraceu...   \n",
       "2  13                    5-HT receptor agonist titration   \n",
       "3  14  Formulations of Psilocin that have enhanced st...   \n",
       "0  15  Formulations of Psilocin that have enhanced st...   \n",
       "1  16  Synergistic cannabinoid esters, their salts an...   \n",
       "0  17  Effects of lysergic acid diethylamide [lsd] an...   \n",
       "1  18  Effects of lysergic acid diethylamide (lsd) an...   \n",
       "0  19  Multi-substituent psilocybin derivatives and m...   \n",
       "1  20  Pharmaceutically acceptable salts of psilocin ...   \n",
       "2  21  Methods of use and formulations of allosteric\\...   \n",
       "0  22  Rapid method of producing non-alcoholic and al...   \n",
       "1  23  Rapid method of producing non-alcoholic and al...   \n",
       "2  24  Prenylated psilocybin derivatives and methods ...   \n",
       "0  25  Activated cannabis products and methods for\\rp...   \n",
       "1  26  Nanoparticle-mediated immune cell manufacture ...   \n",
       "0  27  Systems and methods for pharmaceutical product...   \n",
       "1  28  Treatment of suicidality with psilocin or psil...   \n",
       "0  29  Psilocybin and norbaeocystin compositions and\\...   \n",
       "1  30  Protected alkyl tryptamines and their therapeu...   \n",
       "0  31  Composition for treating opioid withdrawal and...   \n",
       "0  32  Vaporizable psychoactive alkaloid composition ...   \n",
       "1  33  Transmucosal psychoactive alkaloid composition...   \n",
       "0  34  Vaporizable psychoactive alkaloid composition ...   \n",
       "1  35  Transmucosal psychoactive alkaloid composition...   \n",
       "2  36  Compositions and methods for anxiety disorder\\...   \n",
       "0  37              Use of psilocybin in cancer treatment   \n",
       "1  38      Dialkyl trytamines and their therapeutic uses   \n",
       "0  39  Pharmaceutical composition comprising psilocyb...   \n",
       "1  40  Aldehyde and ketone derivatives of psilocybin ...   \n",
       "2  41  Novel psilocin analog compositions and methods...   \n",
       "3  42  Carboxylated psilocybin derivatives and method...   \n",
       "4  43     Compositions and methods for treating migraine   \n",
       "0  44  Compositions and methods for treating neurolog...   \n",
       "1  45                Treatment of anxiety and depression   \n",
       "2  46  Engineered microorganisms for producing substi...   \n",
       "3  47  Compositions and methods for extracting, stabi...   \n",
       "4  48  Thc beverage preparation apparatus and method ...   \n",
       "0  49  Cannabis time release apparatus and method of\\...   \n",
       "1  50  Food / beverage nootropic amendment apparatus ...   \n",
       "\n",
       "                                      Owner/Assignee Patent/Pub. No.  \\\n",
       "0                           Lennham\\rPharmaceuticals    US11,344,564   \n",
       "1                                      Jerred Tudela    US11,419,280   \n",
       "2                                   Psilo Scientific   US20220226405   \n",
       "0                                 Terran Biosciences    WO2022212854   \n",
       "1                       Mycrodose\\rtherapeutics inc.    WO2022212789   \n",
       "2                                    Allen institute    WO2022212585   \n",
       "0                        Compass Pathfinder\\rLimited    WO2022207746   \n",
       "1                                 Mynd Life Sciences    WO2022204802   \n",
       "2                                   Mind Cure Health    WO2022204805   \n",
       "3                                  Cybin IRL Limited    WO2022195011   \n",
       "0                                  Tryp Therapeutics    WO2022195489   \n",
       "1                                       Allied Corp.    WO2022187973   \n",
       "2                              Diamond\\rTherapeutics    WO2022189855   \n",
       "3                                      Mind Medicine   US20220280482   \n",
       "0                                      Mind Medicine    WO2022192097   \n",
       "1  London\\rPharmaceuticals and\\rResearch\\rCorpora...    WO2022183292   \n",
       "0                          Universitatsspital\\rbasel    WO2022175821   \n",
       "1                          Universitatsspital\\rBasel   US20220273628   \n",
       "0                                Enveric Biosciences    WO2022170438   \n",
       "1                               Eleusis Therapeutics    WO2022173888   \n",
       "2                          David Alan Heldreth,\\rJr.   US20220265601   \n",
       "0                                              Ceria    WO2022165387   \n",
       "1                                              Ceria    US11,521,444   \n",
       "2                                Enveric Biosciences    WO2022155751   \n",
       "0                               2655626 Ontario Inc.    WO2022155741   \n",
       "1                 The George\\rWashington\\rUniversity    WO2022150763   \n",
       "0                                   Miami University    WO2022150854   \n",
       "1                                New York University    WO2022150563   \n",
       "0                                   Miami University    WO2022150840   \n",
       "1                                           CaaMTech    WO2022150530   \n",
       "0                                         Mai Nguyen   US20220218649   \n",
       "0                                   Psilo Scientific    WO2022140846   \n",
       "1                                   Psilo Scientific    WO2022140841   \n",
       "0                                   Psilo Scientific   US20220313713   \n",
       "1                                   Psilo Scientific   US20220313762   \n",
       "2                           Psilobrain\\rTherapeutics    WO2022137107   \n",
       "0                                        Silo Pharma    WO2022125949   \n",
       "1                                           CaaMTech    WO2022125616   \n",
       "0                                    Beckley Psytech    WO2022123232   \n",
       "1                                Enveric Biosciences    WO2022115960   \n",
       "2                              Mydecine\\rInnovations    WO2022120181   \n",
       "3                                Enveric Biosciences    WO2022115944   \n",
       "4                                      Wesana Health    WO2022115798   \n",
       "0                                      Wesana Health    WO2022115796   \n",
       "1                                New York University   US20220151993   \n",
       "2                                            Algae-C    WO2022099424   \n",
       "3                                  Richard C Kaufman   US20220054402   \n",
       "4                                Cave; Mason; et al.   US20220125091   \n",
       "0                               Hazen; Kevin; et al.   US20220125755   \n",
       "1                              Roth; Michael; et al.   US20220127058   \n",
       "\n",
       "  Priority Date                                   Status  \\\n",
       "0     20/8/2021  Granted 2022-5-31\\r(expires 2041-12-17)   \n",
       "1     23/7/2021                                Published   \n",
       "2     14/6/2021                                Published   \n",
       "0      1/4/2021                                Published   \n",
       "1     31/3/2021                                Published   \n",
       "2     30/3/2021                                Published   \n",
       "0     30/3/2021                                Published   \n",
       "1     30/3/2021                                Published   \n",
       "2     29/3/2021                                Published   \n",
       "3     18/3/2021                                Published   \n",
       "0     15/3/2021                                Published   \n",
       "1     12/3/2021                                Published   \n",
       "2      8/3/2021                                Published   \n",
       "3      6/3/2021                                Published   \n",
       "0      6/3/2021                                Published   \n",
       "1      3/3/2021                                Published   \n",
       "0     19/2/2021                                Published   \n",
       "1     19/2/2021                                Published   \n",
       "0     12/2/2021                                Published   \n",
       "1     10/2/2021                                Published   \n",
       "2     10/2/2021                                Published   \n",
       "0     31/1/2021                                Published   \n",
       "1     31/1/2021                       Granted 2022-12-06   \n",
       "2     22/1/2021                                Published   \n",
       "0     20/1/2021                                Published   \n",
       "1     11/1/2021                                Published   \n",
       "0     11/1/2021                                Published   \n",
       "1      8/1/2021                                Published   \n",
       "0      8/1/2021                                Published   \n",
       "1      8/1/2021                                Published   \n",
       "0      7/1/2021                                Published   \n",
       "0    28/12/2020                                Published   \n",
       "1    28/12/2020                                Published   \n",
       "0    28/12/2020                                Published   \n",
       "1    28/12/2020                                Published   \n",
       "2    21/12/2020                                Published   \n",
       "0    13/12/2020                                Published   \n",
       "1     9/12/2020                                Published   \n",
       "0     7/12/2020                                Published   \n",
       "1     4/12/2020                                Published   \n",
       "2     3/12/2020                                Published   \n",
       "3     1/12/2020                                Published   \n",
       "4    30/11/2020                                Published   \n",
       "0    30/11/2020                                Published   \n",
       "1    16/11/2020                                Published   \n",
       "2    16/11/2020                                Published   \n",
       "3     5/11/2020                                Published   \n",
       "4    24/10/2020                                Published   \n",
       "0    24/10/2020                                Published   \n",
       "1    24/10/2020                                Published   \n",
       "\n",
       "                              General Subject Matter  \n",
       "0  The method includes determining whether a subj...  \n",
       "1  Methods of crossbreeding fungi organisms. The\\...  \n",
       "2  This invention relates to the extraction of ps...  \n",
       "0  Provided herein are compositions relating to\\r...  \n",
       "1  A drug delivery system is provided for transde...  \n",
       "2  Artificial expression constructs for modulatin...  \n",
       "0  The present disclosure provides pharmaceutical...  \n",
       "1  The present invention provides use of psychede...  \n",
       "2  Computer-implemented methods of treating at le...  \n",
       "3  The present disclosure relates to psilocin com...  \n",
       "0  Provided are improved methods for treating a\\r...  \n",
       "1  The present invention discloses compositions f...  \n",
       "2  Disclosed herein are methods of treating\\rneur...  \n",
       "3  A composition of psilocin that is stable inclu...  \n",
       "0  A composition of psilocin that is stable inclu...  \n",
       "1  Cannabinoid esters and their soluble salts wit...  \n",
       "0  A method of treating anxiety disorders specifi...  \n",
       "1  A method of treating anxiety disorders specifi...  \n",
       "0  Disclosed are novel multi-substitute psilocybi...  \n",
       "1  The present invention features pharmaceuticall...  \n",
       "2  The invention involves the use of formulations...  \n",
       "0  A rapid method of brewing malt beverages havin...  \n",
       "1  A rapid method of brewing malt beverages havin...  \n",
       "2  Disclosed are novel prenylated psilocybin deri...  \n",
       "0  The present disclosure describes cannabis prod...  \n",
       "1  The present disclosure generally relates targe...  \n",
       "0  Provided are systems and methods for the produ...  \n",
       "1  The invention relates to a method of preventin...  \n",
       "0  Provided is a pharmaceutical composition compr...  \n",
       "1  The disclosure relates to protected alkyl tryp...  \n",
       "0  A composition for treating opioid withdrawal a...  \n",
       "0  This liquid composition includes a psychoactiv...  \n",
       "1  A transmucosal psychoactive alkaloid compositi...  \n",
       "0  This liquid composition includes a psychoactiv...  \n",
       "1  A transmucosal psychoactive alkaloid compositi...  \n",
       "2  Composition consisting of psilocybin and croci...  \n",
       "0  Methods of treating and/or alleviating prolife...  \n",
       "1  The disclosure relates to a composition compri...  \n",
       "0  A composition for use in a method of treatment...  \n",
       "1  A chemical compound having the psilocybin mole...  \n",
       "2  Novel psilosin analogs exhibiting enhanced res...  \n",
       "3  A chemical compound having the psilocybin mole...  \n",
       "4  Disclosure features compositions containing\\rc...  \n",
       "0  Disclosure features compositions containing a\\...  \n",
       "1  Method of alleviating depression and/or anxiet...  \n",
       "2  Presented herein are microorganisms for produc...  \n",
       "3  Invention discloses nano-dimensional compositi...  \n",
       "4  A method for preparing and packaging a THC\\rbe...  \n",
       "0  A method for forming a Cannabis product, compr...  \n",
       "1  The invention comprises a method and apparatus...  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result[:50]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "result['year'] = result['Priority Date'].str.extract(r'(\\w{4})')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>#</th>\n",
       "      <th>Title</th>\n",
       "      <th>Owner/Assignee</th>\n",
       "      <th>Patent/Pub. No.</th>\n",
       "      <th>Priority Date</th>\n",
       "      <th>Status</th>\n",
       "      <th>General Subject Matter</th>\n",
       "      <th>year</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Method of treatment based on reduced monoamine...</td>\n",
       "      <td>Lennham\\rPharmaceuticals</td>\n",
       "      <td>US11,344,564</td>\n",
       "      <td>20/8/2021</td>\n",
       "      <td>Granted 2022-5-31\\r(expires 2041-12-17)</td>\n",
       "      <td>The method includes determining whether a subj...</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>Methods of crossbreeding fungi organisms</td>\n",
       "      <td>Jerred Tudela</td>\n",
       "      <td>US11,419,280</td>\n",
       "      <td>23/7/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Methods of crossbreeding fungi organisms. The\\...</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>Methods and compositions comprising psychoacti...</td>\n",
       "      <td>Psilo Scientific</td>\n",
       "      <td>US20220226405</td>\n",
       "      <td>14/6/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>This invention relates to the extraction of ps...</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4</td>\n",
       "      <td>Methods and compositions relating to psychedel...</td>\n",
       "      <td>Terran Biosciences</td>\n",
       "      <td>WO2022212854</td>\n",
       "      <td>1/4/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>Provided herein are compositions relating to\\r...</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5</td>\n",
       "      <td>Transdermal system, formulation, and method fo...</td>\n",
       "      <td>Mycrodose\\rtherapeutics inc.</td>\n",
       "      <td>WO2022212789</td>\n",
       "      <td>31/3/2021</td>\n",
       "      <td>Published</td>\n",
       "      <td>A drug delivery system is provided for transde...</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>220</td>\n",
       "      <td>Cannabinoid candy foodstuff compositions</td>\n",
       "      <td>Insectergy</td>\n",
       "      <td>US20220151980</td>\n",
       "      <td>3/7/2002</td>\n",
       "      <td>Published</td>\n",
       "      <td>Cannabinoid candy foodstuff compositions are\\r...</td>\n",
       "      <td>2002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>221</td>\n",
       "      <td>Modulation of secondary metabolite production ...</td>\n",
       "      <td>Koninklijke DSM\\r(formerly Microbia\\rInc)</td>\n",
       "      <td>US7,229,784B2</td>\n",
       "      <td>19/9/2000</td>\n",
       "      <td>Granted 2007-06-12\\r(expires 2023-06-05)</td>\n",
       "      <td>Improving yield of fungal metabolites in\\rbioe...</td>\n",
       "      <td>2000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>222</td>\n",
       "      <td>Method of inducing therapeutic tranquilization...</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>US3,192,111A</td>\n",
       "      <td>16/2/1959</td>\n",
       "      <td>Granted 1965-06-29\\r(expired 1982-06-29)</td>\n",
       "      <td>Using psilocybin and psilocin to induce tranqu...</td>\n",
       "      <td>1959</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>223</td>\n",
       "      <td>Esters of indoles</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>US3,075,992A</td>\n",
       "      <td>12/9/1958</td>\n",
       "      <td>Granted 1963-01-29\\r(expired 1980-01-29)</td>\n",
       "      <td>Discloses, with coinventor Franz Troxler, the ...</td>\n",
       "      <td>1958</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>224</td>\n",
       "      <td>Obtaining psilocybin and psilocin from fungal ...</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>US3,183,172A</td>\n",
       "      <td>21/2/1958</td>\n",
       "      <td>Granted 1965-05-11\\r(expired 1982-05-11)</td>\n",
       "      <td>Extracting psilocybin and psilocin from fungal...</td>\n",
       "      <td>1958</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>224 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      #                                              Title  \\\n",
       "0     1  Method of treatment based on reduced monoamine...   \n",
       "1     2           Methods of crossbreeding fungi organisms   \n",
       "2     3  Methods and compositions comprising psychoacti...   \n",
       "0     4  Methods and compositions relating to psychedel...   \n",
       "1     5  Transdermal system, formulation, and method fo...   \n",
       "..  ...                                                ...   \n",
       "1   220           Cannabinoid candy foodstuff compositions   \n",
       "2   221  Modulation of secondary metabolite production ...   \n",
       "3   222  Method of inducing therapeutic tranquilization...   \n",
       "4   223                                  Esters of indoles   \n",
       "5   224  Obtaining psilocybin and psilocin from fungal ...   \n",
       "\n",
       "                               Owner/Assignee Patent/Pub. No. Priority Date  \\\n",
       "0                    Lennham\\rPharmaceuticals    US11,344,564     20/8/2021   \n",
       "1                               Jerred Tudela    US11,419,280     23/7/2021   \n",
       "2                            Psilo Scientific   US20220226405     14/6/2021   \n",
       "0                          Terran Biosciences    WO2022212854      1/4/2021   \n",
       "1                Mycrodose\\rtherapeutics inc.    WO2022212789     31/3/2021   \n",
       "..                                        ...             ...           ...   \n",
       "1                                  Insectergy   US20220151980      3/7/2002   \n",
       "2   Koninklijke DSM\\r(formerly Microbia\\rInc)   US7,229,784B2     19/9/2000   \n",
       "3                                      Sandoz    US3,192,111A     16/2/1959   \n",
       "4                                      Sandoz    US3,075,992A     12/9/1958   \n",
       "5                                      Sandoz    US3,183,172A     21/2/1958   \n",
       "\n",
       "                                      Status  \\\n",
       "0    Granted 2022-5-31\\r(expires 2041-12-17)   \n",
       "1                                  Published   \n",
       "2                                  Published   \n",
       "0                                  Published   \n",
       "1                                  Published   \n",
       "..                                       ...   \n",
       "1                                  Published   \n",
       "2   Granted 2007-06-12\\r(expires 2023-06-05)   \n",
       "3   Granted 1965-06-29\\r(expired 1982-06-29)   \n",
       "4   Granted 1963-01-29\\r(expired 1980-01-29)   \n",
       "5   Granted 1965-05-11\\r(expired 1982-05-11)   \n",
       "\n",
       "                               General Subject Matter  year  \n",
       "0   The method includes determining whether a subj...  2021  \n",
       "1   Methods of crossbreeding fungi organisms. The\\...  2021  \n",
       "2   This invention relates to the extraction of ps...  2021  \n",
       "0   Provided herein are compositions relating to\\r...  2021  \n",
       "1   A drug delivery system is provided for transde...  2021  \n",
       "..                                                ...   ...  \n",
       "1   Cannabinoid candy foodstuff compositions are\\r...  2002  \n",
       "2   Improving yield of fungal metabolites in\\rbioe...  2000  \n",
       "3   Using psilocybin and psilocin to induce tranqu...  1959  \n",
       "4   Discloses, with coinventor Franz Troxler, the ...  1958  \n",
       "5   Extracting psilocybin and psilocin from fungal...  1958  \n",
       "\n",
       "[224 rows x 8 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "result_=result[['Title','Owner/Assignee', 'year']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Owner/Assignee</th>\n",
       "      <th>year</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Method of treatment based on reduced monoamine...</td>\n",
       "      <td>Lennham\\rPharmaceuticals</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Methods of crossbreeding fungi organisms</td>\n",
       "      <td>Jerred Tudela</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Methods and compositions comprising psychoacti...</td>\n",
       "      <td>Psilo Scientific</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Methods and compositions relating to psychedel...</td>\n",
       "      <td>Terran Biosciences</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Transdermal system, formulation, and method fo...</td>\n",
       "      <td>Mycrodose\\rtherapeutics inc.</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Cannabinoid candy foodstuff compositions</td>\n",
       "      <td>Insectergy</td>\n",
       "      <td>2002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Modulation of secondary metabolite production ...</td>\n",
       "      <td>Koninklijke DSM\\r(formerly Microbia\\rInc)</td>\n",
       "      <td>2000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Method of inducing therapeutic tranquilization...</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1959</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Esters of indoles</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1958</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Obtaining psilocybin and psilocin from fungal ...</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1958</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>224 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                Title  \\\n",
       "0   Method of treatment based on reduced monoamine...   \n",
       "1            Methods of crossbreeding fungi organisms   \n",
       "2   Methods and compositions comprising psychoacti...   \n",
       "0   Methods and compositions relating to psychedel...   \n",
       "1   Transdermal system, formulation, and method fo...   \n",
       "..                                                ...   \n",
       "1            Cannabinoid candy foodstuff compositions   \n",
       "2   Modulation of secondary metabolite production ...   \n",
       "3   Method of inducing therapeutic tranquilization...   \n",
       "4                                   Esters of indoles   \n",
       "5   Obtaining psilocybin and psilocin from fungal ...   \n",
       "\n",
       "                               Owner/Assignee  year  \n",
       "0                    Lennham\\rPharmaceuticals  2021  \n",
       "1                               Jerred Tudela  2021  \n",
       "2                            Psilo Scientific  2021  \n",
       "0                          Terran Biosciences  2021  \n",
       "1                Mycrodose\\rtherapeutics inc.  2021  \n",
       "..                                        ...   ...  \n",
       "1                                  Insectergy  2002  \n",
       "2   Koninklijke DSM\\r(formerly Microbia\\rInc)  2000  \n",
       "3                                      Sandoz  1959  \n",
       "4                                      Sandoz  1958  \n",
       "5                                      Sandoz  1958  \n",
       "\n",
       "[224 rows x 3 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result_"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\cynhe\\AppData\\Local\\Temp\\ipykernel_22224\\633389333.py:1: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  result_['Owner/Assignee'] = result_['Owner/Assignee'].str.replace(r'\\r',' ',regex=True)\n"
     ]
    }
   ],
   "source": [
    "result_['Owner/Assignee'] = result_['Owner/Assignee'].str.replace(r'\\r',' ',regex=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Owner/Assignee</th>\n",
       "      <th>year</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Method of treatment based on reduced monoamine...</td>\n",
       "      <td>Lennham Pharmaceuticals</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Methods of crossbreeding fungi organisms</td>\n",
       "      <td>Jerred Tudela</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Methods and compositions comprising psychoacti...</td>\n",
       "      <td>Psilo Scientific</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Methods and compositions relating to psychedel...</td>\n",
       "      <td>Terran Biosciences</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Transdermal system, formulation, and method fo...</td>\n",
       "      <td>Mycrodose therapeutics inc.</td>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Cannabinoid candy foodstuff compositions</td>\n",
       "      <td>Insectergy</td>\n",
       "      <td>2002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Modulation of secondary metabolite production ...</td>\n",
       "      <td>Koninklijke DSM (formerly Microbia Inc)</td>\n",
       "      <td>2000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Method of inducing therapeutic tranquilization...</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1959</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Esters of indoles</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1958</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Obtaining psilocybin and psilocin from fungal ...</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1958</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>224 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                Title  \\\n",
       "0   Method of treatment based on reduced monoamine...   \n",
       "1            Methods of crossbreeding fungi organisms   \n",
       "2   Methods and compositions comprising psychoacti...   \n",
       "0   Methods and compositions relating to psychedel...   \n",
       "1   Transdermal system, formulation, and method fo...   \n",
       "..                                                ...   \n",
       "1            Cannabinoid candy foodstuff compositions   \n",
       "2   Modulation of secondary metabolite production ...   \n",
       "3   Method of inducing therapeutic tranquilization...   \n",
       "4                                   Esters of indoles   \n",
       "5   Obtaining psilocybin and psilocin from fungal ...   \n",
       "\n",
       "                             Owner/Assignee  year  \n",
       "0                   Lennham Pharmaceuticals  2021  \n",
       "1                             Jerred Tudela  2021  \n",
       "2                          Psilo Scientific  2021  \n",
       "0                        Terran Biosciences  2021  \n",
       "1               Mycrodose therapeutics inc.  2021  \n",
       "..                                      ...   ...  \n",
       "1                                Insectergy  2002  \n",
       "2   Koninklijke DSM (formerly Microbia Inc)  2000  \n",
       "3                                    Sandoz  1959  \n",
       "4                                    Sandoz  1958  \n",
       "5                                    Sandoz  1958  \n",
       "\n",
       "[224 rows x 3 columns]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result_"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "#result_.to_csv('../DataBases/Psilocib_march08.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "import glob\n",
    "import os"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "path = r\"D:\\Data Visualization CENTRO\\Cuatrimestre III\\Proyecto final\\DataBases\\CSV TRACKING\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "all_files = glob.glob(os.path.join(path, \"*.csv\"))\n",
    "\n",
    "track_f = pd.concat((pd.read_csv(f) for f in all_files), ignore_index=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>Title</th>\n",
       "      <th>Owner/Assignee</th>\n",
       "      <th>year</th>\n",
       "      <th>Substance</th>\n",
       "      <th>Unnamed: 5</th>\n",
       "      <th>Unnamed: 6</th>\n",
       "      <th>Unnamed: 7</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>Terran Biosciences</td>\n",
       "      <td>Terran Biosciences</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Mycrodose therapeutics inc.</td>\n",
       "      <td>Mycrodose therapeutics inc.</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>Allen institute</td>\n",
       "      <td>Allen institute</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0</td>\n",
       "      <td>Mind Cure Health, Inc.</td>\n",
       "      <td>Mind Cure Health, Inc.</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1</td>\n",
       "      <td>Small Pharma</td>\n",
       "      <td>Small Pharma</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>598</th>\n",
       "      <td>1</td>\n",
       "      <td>Cannabinoid candy foodstuff compositions</td>\n",
       "      <td>Insectergy</td>\n",
       "      <td>2002</td>\n",
       "      <td>Psilocybin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>599</th>\n",
       "      <td>2</td>\n",
       "      <td>Modulation of secondary metabolite production ...</td>\n",
       "      <td>Koninklijke DSM (formerly Microbia Inc)</td>\n",
       "      <td>2000</td>\n",
       "      <td>Psilocybin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600</th>\n",
       "      <td>3</td>\n",
       "      <td>Method of inducing therapeutic tranquilization...</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1959</td>\n",
       "      <td>Psilocybin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>601</th>\n",
       "      <td>4</td>\n",
       "      <td>Esters of indoles</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1958</td>\n",
       "      <td>Psilocybin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>602</th>\n",
       "      <td>5</td>\n",
       "      <td>Obtaining psilocybin and psilocin from fungal ...</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1958</td>\n",
       "      <td>Psilocybin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>603 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     Unnamed: 0                                              Title  \\\n",
       "0             0                                 Terran Biosciences   \n",
       "1             1                        Mycrodose therapeutics inc.   \n",
       "2             2                                    Allen institute   \n",
       "3             0                             Mind Cure Health, Inc.   \n",
       "4             1                                       Small Pharma   \n",
       "..          ...                                                ...   \n",
       "598           1           Cannabinoid candy foodstuff compositions   \n",
       "599           2  Modulation of secondary metabolite production ...   \n",
       "600           3  Method of inducing therapeutic tranquilization...   \n",
       "601           4                                  Esters of indoles   \n",
       "602           5  Obtaining psilocybin and psilocin from fungal ...   \n",
       "\n",
       "                              Owner/Assignee  year   Substance  Unnamed: 5  \\\n",
       "0                         Terran Biosciences  2021         DMT         NaN   \n",
       "1                Mycrodose therapeutics inc.  2021         DMT         NaN   \n",
       "2                            Allen institute  2021         DMT         NaN   \n",
       "3                     Mind Cure Health, Inc.  2021         DMT         NaN   \n",
       "4                               Small Pharma  2021         DMT         NaN   \n",
       "..                                       ...   ...         ...         ...   \n",
       "598                               Insectergy  2002  Psilocybin         NaN   \n",
       "599  Koninklijke DSM (formerly Microbia Inc)  2000  Psilocybin         NaN   \n",
       "600                                   Sandoz  1959  Psilocybin         NaN   \n",
       "601                                   Sandoz  1958  Psilocybin         NaN   \n",
       "602                                   Sandoz  1958  Psilocybin         NaN   \n",
       "\n",
       "     Unnamed: 6  Unnamed: 7  \n",
       "0           NaN         NaN  \n",
       "1           NaN         NaN  \n",
       "2           NaN         NaN  \n",
       "3           NaN         NaN  \n",
       "4           NaN         NaN  \n",
       "..          ...         ...  \n",
       "598         NaN         NaN  \n",
       "599         NaN         NaN  \n",
       "600         NaN         NaN  \n",
       "601         NaN         NaN  \n",
       "602         NaN         NaN  \n",
       "\n",
       "[603 rows x 8 columns]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "track_f"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "track_f2 = track_f.drop(columns=['Unnamed: 5',\t'Unnamed: 6',\t'Unnamed: 7'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "#track_f2.to_csv('.Substance_time_patents.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "pivot = pd.read_csv('./Substance_time_patents.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Owner/Assignee</th>\n",
       "      <th>year</th>\n",
       "      <th>Substance</th>\n",
       "      <th>Unnamed: 4</th>\n",
       "      <th>Unnamed: 5</th>\n",
       "      <th>Unnamed: 6</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Terran Biosciences</td>\n",
       "      <td>Terran Biosciences</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Mycrodose therapeutics inc.</td>\n",
       "      <td>Mycrodose therapeutics inc.</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Allen institute</td>\n",
       "      <td>Allen institute</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Mind Cure Health, Inc.</td>\n",
       "      <td>Mind Cure Health, Inc.</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Small Pharma</td>\n",
       "      <td>Small Pharma</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>598</th>\n",
       "      <td>Cannabinoid candy foodstuff compositions</td>\n",
       "      <td>Insectergy</td>\n",
       "      <td>2002</td>\n",
       "      <td>Psilocybin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>599</th>\n",
       "      <td>Modulation of secondary metabolite production ...</td>\n",
       "      <td>Koninklijke DSM (formerly Microbia Inc)</td>\n",
       "      <td>2000</td>\n",
       "      <td>Psilocybin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600</th>\n",
       "      <td>Method of inducing therapeutic tranquilization...</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1959</td>\n",
       "      <td>Psilocybin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>601</th>\n",
       "      <td>Esters of indoles</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1958</td>\n",
       "      <td>Psilocybin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>602</th>\n",
       "      <td>Obtaining psilocybin and psilocin from fungal ...</td>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1958</td>\n",
       "      <td>Psilocybin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>603 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                 Title  \\\n",
       "0                                   Terran Biosciences   \n",
       "1                          Mycrodose therapeutics inc.   \n",
       "2                                      Allen institute   \n",
       "3                               Mind Cure Health, Inc.   \n",
       "4                                         Small Pharma   \n",
       "..                                                 ...   \n",
       "598           Cannabinoid candy foodstuff compositions   \n",
       "599  Modulation of secondary metabolite production ...   \n",
       "600  Method of inducing therapeutic tranquilization...   \n",
       "601                                  Esters of indoles   \n",
       "602  Obtaining psilocybin and psilocin from fungal ...   \n",
       "\n",
       "                              Owner/Assignee  year   Substance  Unnamed: 4  \\\n",
       "0                         Terran Biosciences  2021         DMT         NaN   \n",
       "1                Mycrodose therapeutics inc.  2021         DMT         NaN   \n",
       "2                            Allen institute  2021         DMT         NaN   \n",
       "3                     Mind Cure Health, Inc.  2021         DMT         NaN   \n",
       "4                               Small Pharma  2021         DMT         NaN   \n",
       "..                                       ...   ...         ...         ...   \n",
       "598                               Insectergy  2002  Psilocybin         NaN   \n",
       "599  Koninklijke DSM (formerly Microbia Inc)  2000  Psilocybin         NaN   \n",
       "600                                   Sandoz  1959  Psilocybin         NaN   \n",
       "601                                   Sandoz  1958  Psilocybin         NaN   \n",
       "602                                   Sandoz  1958  Psilocybin         NaN   \n",
       "\n",
       "     Unnamed: 5  Unnamed: 6  \n",
       "0           NaN         NaN  \n",
       "1           NaN         NaN  \n",
       "2           NaN         NaN  \n",
       "3           NaN         NaN  \n",
       "4           NaN         NaN  \n",
       "..          ...         ...  \n",
       "598         NaN         NaN  \n",
       "599         NaN         NaN  \n",
       "600         NaN         NaN  \n",
       "601         NaN         NaN  \n",
       "602         NaN         NaN  \n",
       "\n",
       "[603 rows x 7 columns]"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pivot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [],
   "source": [
    "pivot2 = pivot.drop(columns=['Title','Unnamed: 4',\t'Unnamed: 5',\t'Unnamed: 6'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Owner/Assignee</th>\n",
       "      <th>year</th>\n",
       "      <th>Substance</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Terran Biosciences</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Mycrodose therapeutics inc.</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Allen institute</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Mind Cure Health, Inc.</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Small Pharma</td>\n",
       "      <td>2021</td>\n",
       "      <td>DMT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>598</th>\n",
       "      <td>Insectergy</td>\n",
       "      <td>2002</td>\n",
       "      <td>Psilocybin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>599</th>\n",
       "      <td>Koninklijke DSM (formerly Microbia Inc)</td>\n",
       "      <td>2000</td>\n",
       "      <td>Psilocybin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600</th>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1959</td>\n",
       "      <td>Psilocybin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>601</th>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1958</td>\n",
       "      <td>Psilocybin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>602</th>\n",
       "      <td>Sandoz</td>\n",
       "      <td>1958</td>\n",
       "      <td>Psilocybin</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>603 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                              Owner/Assignee  year   Substance\n",
       "0                         Terran Biosciences  2021         DMT\n",
       "1                Mycrodose therapeutics inc.  2021         DMT\n",
       "2                            Allen institute  2021         DMT\n",
       "3                     Mind Cure Health, Inc.  2021         DMT\n",
       "4                               Small Pharma  2021         DMT\n",
       "..                                       ...   ...         ...\n",
       "598                               Insectergy  2002  Psilocybin\n",
       "599  Koninklijke DSM (formerly Microbia Inc)  2000  Psilocybin\n",
       "600                                   Sandoz  1959  Psilocybin\n",
       "601                                   Sandoz  1958  Psilocybin\n",
       "602                                   Sandoz  1958  Psilocybin\n",
       "\n",
       "[603 rows x 3 columns]"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pivot2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {},
   "outputs": [],
   "source": [
    "count = pivot2.groupby(['Substance', 'year']).count().reset_index()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "metadata": {},
   "outputs": [],
   "source": [
    "#count.to_csv('./substancevsyears.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "c7f150e609b07d99aad3a4a27bdccca5bb1500101f3d57e0b9abdd6fbb3fce4c"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
